---

DIABETIC AUTONOMIC NEUROPATHY (DAN) — ANAESTHESIA IMPLICATIONS

DNB Final Anaesthesia | 10-Mark Model Answer

---

1. INTRODUCTION

• Unpredictable haemodynamic instability under anaesthesia
• Impaired protective airway reflexes → aspiration risk
• Gastric stasis (gastroparesis) → full stomach risk
• Inability to mount tachycardia in response to hypovolaemia
• Silent myocardial ischaemia masking perioperative MI
• Altered drug pharmacokinetics and temperature regulation

"Anaesthesia in a diabetic with autonomic neuropathy is like flying blind in turbulence — without the aircraft's warning systems."

---

2. APPLIED ANATOMY / PHYSIOLOGY

Autonomic Nervous System — Relevant Architecture

                    ┌─────────────────────────────────┐
                    │        HYPOTHALAMUS              │
                    │  (Central ANS Integration)       │
                    └──────────┬──────────────────────┘
                               │
              ┌────────────────┴───────────────────┐
              ▼                                     ▼
    SYMPATHETIC (T1–L2)               PARASYMPATHETIC (CN III,VII,IX,X; S2–S4)
    Preganglionic → Paravertebral      Preganglionic → Terminal/Wall ganglia
    NT: Norepinephrine (NE)            NT: Acetylcholine (ACh)
              │                                     │
    ┌─────────┴──────────┐              ┌───────────┴──────────┐
    Heart  Vessels  GIT  Sweat          Heart (vagus) GIT Bladder
    ↑HR    Vasoconstrict Motility↓      ↓HR           Motility↑

Physiological Targets Disrupted in DAN:

---

3. CLASSIFICATION / ETIOLOGY

Classification of DAN (by system):

Etiology / Risk Factors:

Chronic Hyperglycaemia
        │
        ├─► Polyol pathway activation (sorbitol accumulation)
        ├─► Advanced Glycation End-products (AGEs)
        ├─► Oxidative stress → free radical damage to nerve
        ├─► Microvascular ischaemia of vasa nervorum
        └─► Impaired neurotrophic support (IGF-1, NGF)

---

4. PATHOPHYSIOLOGY

CHRONIC HYPERGLYCAEMIA
         │
         ▼
┌─────────────────────────────────────────────────────┐
│  Metabolic Injury to Autonomic Nerve Fibres         │
│  (Preferentially small unmyelinated C-fibres first) │
└─────────────────────────┬───────────────────────────┘
                          │
          ┌───────────────┼───────────────────┐
          ▼               ▼                   ▼
   Polyol pathway    AGE formation        Oxidative stress
   (Sorbitol↑,       (Myelin damage,      (Mitochondrial
   Fructose↑)        Axonal loss)          dysfunction)
          │               │                   │
          └───────────────┼───────────────────┘
                          ▼
             Microvascular ischaemia
             of vasa nervorum
                          │
                          ▼
         Loss of Myelinated + Unmyelinated fibres
         Sympathetic ganglion vacuolation
         Loss of vagal + splanchnic myelinated fibres
                          │
          ┌───────────────┼─────────────────────────┐
          ▼               ▼                         ▼
  Cardiovascular     Gastrointestinal          Sudomotor/
  Autonomic          Dysmotility               Thermoregulatory
  Neuropathy         (Gastroparesis)           Failure
          │               │
          ▼               ▼
  ↓Baroreflex       Delayed gastric          ◄── ANAESTHESIA
  sensitivity       emptying                     RISK ZONE
  Fixed HR          Full stomach
  Orthostatic ↓BP   Aspiration
  Silent MI
          │
          ▼
  ☠ INTRAOPERATIVE HAEMODYNAMIC CRISIS
    - Profound hypotension on induction
    - No compensatory tachycardia
    - Cardiovascular collapse

---

5. CLINICAL FEATURES

A. Cardiovascular (Most critical for anaesthesia)

• Resting tachycardia (HR >100 at rest, earliest sign)
• Fixed heart rate (loss of beat-to-beat variability — R-R interval fixed)
• Orthostatic hypotension (>20 mmHg systolic or >10 mmHg diastolic drop on standing)
• Exercise intolerance
• Silent myocardial ischaemia (no angina due to sensory denervation)
• Nocturnal hypertension / loss of normal dip

B. Gastrointestinal

• Nausea, vomiting, early satiety (gastroparesis)
• Bloating, abdominal distension
• Nocturnal diarrhoea / constipation alternating

C. Genitourinary

• Urinary hesitancy, retention, overflow incontinence

D. Thermoregulatory / Sudomotor

• Anhidrosis (distal extremities), compensatory hyperhidrosis (trunk)

E. Hypoglycaemia Unawareness

• Loss of adrenergic symptoms (tremor, palpitations) → silent hypoglycaemia

---

⚠️ ANAESTHESIA IMPLICATIONS BOX

Feature	Anaesthetic Consequence
Orthostatic hypotension	Profound hypotension on induction / position change
Fixed HR	Cannot use HR as haemodynamic monitor
Gastroparesis	RSI mandatory — full stomach protocol
Silent MI	ECG + troponin baseline; continuous ST monitoring
Thermoregulation failure	Active warming essential
Hypoglycaemia unawareness	Continuous glucose monitoring intraoperatively

---

6. INVESTIGATIONS

Routine

• ECG — resting tachycardia, ST changes, prolonged QTc (risk of arrhythmia)
• HbA1c — glycaemic control assessment
• Fasting blood glucose + RBS
• Renal function tests — eGFR, creatinine (co-existing nephropathy)
• Serum electrolytes — K⁺ (arrhythmia risk with QTc prolongation)
• Echocardiography — LV dysfunction, wall motion abnormalities
• Gastric emptying scan (Tc-99m) — if gastroparesis suspected

Specific Tests for CAN (Ewing's Battery — GOLD STANDARD)

• Heart Rate Variability (HRV) analysis — SDNN <50 ms suggests significant CAN
• MIBG scintigraphy — functional cardiac sympathetic innervation
• Tilt-table test — for orthostatic hypotension quantification

---

7. MANAGEMENT (HIGHEST WEIGHTAGE)

A. PREOPERATIVE OPTIMIZATION

Risk Stratification

DAN Severity → Ewing's Battery
        │
        ├── 0–1 abnormal → Low risk → Proceed with standard precautions
        ├── 2–3 abnormal → Moderate risk → Optimize, ICU postop
        └── 4–5 abnormal → High risk → Multidisciplinary review, delay elective surgery

Optimization Steps:

1. Glycaemic control: HbA1c <8% preferred preoperatively (ADA 2023 guidelines). Avoid hypoglycaemia — target glucose 140–180 mg/dL perioperative.
2. Cardiovascular: Identify silent CAD (stress echo/nuclear scan). Continue beta-blockers (avoid abrupt withdrawal). Optimise for prolonged QTc (electrolyte correction).
3. Gastroparesis protocol:
   • NPO 8 hours solids; clear liquids 2 hours (modified — may need longer in gastroparesis)
   • Prokinetic: Metoclopramide 10 mg IV 30 min preop
   • H₂-blocker: Ranitidine 150 mg oral night before + 150 mg morning (or PPI equivalent)
   • Sodium citrate 30 mL oral 15 min before induction
4. Antihypertensive management: Continue ACE-inhibitors/ARBs with caution (risk of intraoperative hypotension — consider withholding morning dose, per AHA/ACC perioperative guidelines 2014)
5. Premedication: Avoid agents causing vagal suppression (atropine premedication may not produce expected tachycardia). Minimize opioid premedication (↑PONV risk + delayed gastric emptying).

---

B. INTRAOPERATIVE MANAGEMENT

Monitoring (Mandatory in CAN)

Induction — CRITICAL PHASE

GASTROPARESIS PRESENT?
        │
        YES → RAPID SEQUENCE INDUCTION (RSI)
        │     ├── Pre-oxygenate 3 min (FiO₂ 1.0)
        │     ├── Cricoid pressure (Sellick's)
        │     ├── Thiopentone 3–5 mg/kg IV (or Propofol 1.5–2 mg/kg carefully)
        │     ├── Succinylcholine 1.5 mg/kg IV
        │     └── Intubate with cuffed ETT, confirm ETCO₂
        │
        NO → Modified RSI or standard induction with
              vasopressor co-induction

Propofol caution: Produces pronounced vasodilation → profound hypotension in CAN. Reduce dose by 30–40%. Use incremental titrated doses.

Ketamine advantage: Sympathomimetic — maintains BP. Consider 0.5–1 mg/kg as co-induction or sole agent in haemodynamic compromise.

Drug Table — Induction Agents

Etomidate preferred for haemodynamically compromised patients with severe CAN.

Maintenance

Vasopressors (Essential preparation — draw up BEFORE induction)

---

C. POSTOPERATIVE CARE

1. ICU / HDU admission for moderate-severe CAN (Level 2/3 care)
2. Haemodynamic monitoring continued — orthostatic hypotension on sitting/mobilisation
3. Multimodal analgesia — minimise opioids (↑PONV, delayed gastric motility):
   • Paracetamol 1g IV q6h
   • NSAIDs (if renal function adequate)
   • Regional/neuraxial analgesia preferred
4. Antiemetic prophylaxis (gastroparesis + opioid → PONV high risk):
   • Ondansetron 4 mg IV
   • Dexamethasone 4–8 mg IV
   • Consider droperidol 0.625 mg (but QTc monitoring needed)
5. Continue glucose monitoring q1–2 hourly
6. Early mobilization with assistance (orthostatic hypotension risk)
7. Subcutaneous heparin — DVT prophylaxis (neurogenic bladder, immobility)

---

D. CRISIS ALGORITHM — INTRAOPERATIVE HYPOTENSION IN DAN

SEVERE HYPOTENSION (MAP <50 mmHg) DURING ANAESTHESIA IN DAN
                    │
                    ▼
         Is patient responding to vasopressors?
          │                          │
         YES                         NO
          │                          │
    Titrate Noradrenaline      Rule out:
    0.05–0.3 µg/kg/min         ├─ Pneumothorax
                                ├─ Anaphylaxis
                                ├─ MI (12-lead ECG → troponin)
                                ├─ Massive haemorrhage
                                └─ PE
                                          │
                                   If haemodynamic collapse:
                                   → Vasopressin 0.04 units/min
                                   → Hydrocortisone 200 mg IV
                                     (relative adrenal insufficiency)
                                   → Call for help — Activate MET

---

8. COMPLICATIONS

---

9. RECENT ADVANCES & GUIDELINES UPDATE

---

10. QUICK REVISION SUMMARY BOX

╔══════════════════════════════════════════════════════════════╗
║          DIABETIC AUTONOMIC NEUROPATHY — VIVA PEARLS         ║
╠══════════════════════════════════════════════════════════════╣
║ MNEMONIC: "GRAPHS" = Gastroparesis, Resting tachycardia,    ║
║ Anhidrosis, Postural hypotension, Hypoglycaemia unawareness, ║
║ Silent MI                                                    ║
╠══════════════════════════════════════════════════════════════╣
║ ✦ Earliest sign of CAN = Resting tachycardia (>100/min)     ║
║ ✦ Gold Standard diagnosis = Ewing's Battery (≥2 abnormal)   ║
║ ✦ RSI MANDATORY in gastroparesis — always assume full stomach║
║ ✦ Etomidate = most haemodynamically stable induction agent   ║
║ ✦ Fixed HR = cannot use HR as haemodynamic monitor → use IBP║
║ ✦ QTc prolongation → arrhythmia risk → avoid drugs that     ║
║   prolong QT (droperidol, haloperidol, neostigmine)          ║
║ ✦ Propofol causes profound ↓BP in CAN — reduce dose ≥30-40% ║
║ ✦ Vasopressor of choice: Noradrenaline infusion              ║
║ ✦ Draw up vasopressors BEFORE induction — do not wait        ║
║ ✦ Sevoflurane preferred volatile (least arrhythmogenic)      ║
║ ✦ Postop: ICU/HDU, multimodal analgesia, early glucose check ║
╠══════════════════════════════════════════════════════════════╣
║ COMMON MISTAKES TO AVOID:                                    ║
║ ✗ Forgetting RSI in gastroparesis patient                    ║
║ ✗ Using HR alone as haemodynamic guide in fixed-HR patient   ║
║ ✗ Not having vasopressors drawn up before induction          ║
║ ✗ Missing silent MI — always take baseline ECG + troponin    ║
║ ✗ Skipping temperature monitoring                            ║
╚══════════════════════════════════════════════════════════════╝

---

• Miller's Anaesthesia, 9th Ed — Chapter on Endocrine Disorders & Anaesthesia
• Barash Clinical Anaesthesia, 9th Ed — Perioperative management of diabetic complications
• Morgan & Mikhail's Clinical Anaesthesiology, 6th Ed — Autonomic nervous system pharmacology
• Adams & Victor's Principles of Neurology, 12th Ed — Diabetic Neuropathies
• Stoelting's Anaesthesia & Co-existing Disease — Diabetes mellitus chapter

---

CNS PHYSIOLOGY — DNB FINAL ANAESTHESIA

Complete Answers (Questions 1–8)

---

Q1 & Q2 — REGULATION OF CEREBRAL BLOOD FLOW (CBF) + EFFECT OF ANAESTHETIC DRUGS

INTRODUCTION

• Normal CBF = 50–65 mL/100 g/min (whole brain ~750–900 mL/min)
• Brain = 2% body weight but receives 15% cardiac output and consumes 20% total body O₂
• Normal CMRO₂ = 3.5 mL O₂/100 g/min
• Precise CBF regulation is vital: the non-compliant cranium permits no excess blood volume without ICP rise

---

FACTORS REGULATING CBF

A. Chemical / Metabolic Regulation (Most important)

1. Carbon Dioxide (CO₂) — Most potent vasodilator

↑PaCO₂ → CO₂ + H₂O → H₂CO₃ → H⁺ (carbonic acid dissociation)
              │
              ▼
    H⁺ directly dilates cerebral arterioles
              │
              ▼
        ↑CBF (almost linearly)

• Range of response: PaCO₂ 20–80 mmHg (linear relationship)
• Beyond this range → maximal vasoconstriction/dilation, no further change
• Anaesthesia implication: Hyperventilation (↓PaCO₂) → cerebral vasoconstriction → ↓CBF → ↓ICP — cornerstone of neuro-anaesthetic ICP management

2. Oxygen

PaO₂ > 60 mmHg → NO effect on CBF
PaO₂ < 50 mmHg → SHARP ↑CBF (hypoxic cerebral vasodilation)
PaO₂ = 30 mmHg → CBF doubles

3. pH / H⁺ Ions

• Direct vasodilatory effect on smooth muscle
• ↑H⁺ (acidosis) → ↑CBF; Alkalosis → ↓CBF

4. Metabolic Coupling (Flow-Metabolism Coupling)

• Local neuronal activity ↑ → adenosine, K⁺, H⁺, lactate released → local vasodilation → ↑regional CBF
• Coupling ratio: CBF/CMRO₂ remains constant normally

---

B. Pressure / Myogenic Autoregulation

CPP (MAP - ICP) range: 50–150 mmHg
        │
        ├── Within this range → CBF remains CONSTANT (50 mL/100g/min)
        │   (Bayliss myogenic response — stretch → vasoconstriction)
        │
        ├── CPP < 50 mmHg → Autoregulation FAILS → CBF falls → ischaemia
        └── CPP > 150 mmHg → Autoregulation FAILS → ↑CBF → oedema, haemorrhage

CBF
(mL/100g/min)
   |
50 |_________ _________
   |          |         |
   |         /           \
   |        /             \
   |_______/               \____________
   0      50              150           MAP (mmHg)
          ↑               ↑
        LLA             ULA
      (Lower limit     (Upper limit
       autoregulation)  autoregulation)

---

C. Neurogenic Regulation

• Sympathetic (NE): vasoconstriction (minor role in baseline)
• Parasympathetic (ACh): vasodilation
• Primarily shifts the autoregulation curve rather than directly controlling resting CBF

---

D. Viscosity

• ↑Haematocrit → ↑viscosity → ↓CBF
• Optimal Hct for CBF = 30–35% (rheological optimum)

---

EFFECT OF ANAESTHETIC DRUGS ON CBF

Volatile Anaesthetic Agents

Key principle: All volatile agents cause dose-dependent cerebral vasodilation (↑CBF) while simultaneously reducing CMRO₂ — this uncoupling of CBF from metabolic demand is the hallmark concern in neuro-anaesthesia.

Sevoflurane is preferred for neuroanesthesia: least ICP elevation, best preservation of autoregulation, maintains coupling at <1 MAC.

Intravenous Agents

Ketamine caveat (2020 update): Recent evidence (Himmelseher et al.) suggests ketamine may be safe or even beneficial in ventilated patients with controlled ICP when combined with propofol — dogmatic contraindication is being re-evaluated.

---

Neuromuscular Agents

---

QUICK SUMMARY BOX — CBF REGULATION

╔═══════════════════════════════════════════════════════════╗
║  MNEMONIC: "CO₂ is KING of CBF"                          ║
║  CO₂ > O₂ > MAP (autoregulation) > Viscosity > Neural   ║
╠═══════════════════════════════════════════════════════════╣
║ • Normal CBF = 50 mL/100g/min                            ║
║ • CO₂ reactivity: 1–2 mL/100g/min per mmHg PaCO₂        ║
║ • Autoregulation: CPP 50–150 mmHg (LLA=50, ULA=150)     ║
║ • PaO₂ <50 → sharp ↑CBF                                  ║
║ • Sevoflurane = safest volatile for neuro-anaesthesia     ║
║ • Propofol = drug of choice for TIVA in neurosurgery     ║
║ • Ketamine contraindicated in raised ICP (classic view)  ║
║ • Hyperventilation (PaCO₂ 30–35) → ↓CBF → ↓ICP         ║
╚═══════════════════════════════════════════════════════════╝

---

---

Q3 & Q4 — INTRACRANIAL PRESSURE (ICP): REGULATION + EFFECT OF ANAESTHESIA

INTRODUCTION

• Normal ICP: 5–15 mmHg (supine adult)
• Raised ICP (intracranial hypertension): >20 mmHg
• Sustained ICP >20 mmHg = threshold for intervention (BTF Guidelines 2022)

---

MONROE-KELLIE DOCTRINE

Rigid cranial vault = FIXED total volume

Volume(Brain) + Volume(CSF) + Volume(Blood) = CONSTANT
    ~80%           ~10%            ~10%

Compensatory mechanism: ↑ in any one component →
compensated initially by displacement of CSF/venous blood

Once compensation exhausted → exponential ↑ ICP

ICP
(mmHg)
  |
40|                                    /
  |                                   /
30|                                  /
  |                              ___/
20|__________________________---
  |
10|
  |
  0_________________________________
        Volume →
        ↑ (Compensated)    ↑ (Decompensated)

• Flat portion = compensated (CSF/blood displacement)
• Steep portion = decompensated → small volume ↑ → massive ICP ↑

---

DETERMINANTS OF ICP

1. CSF Dynamics (Primary regulator)

• CSF produced: 0.35 mL/min (500 mL/day) — choroid plexus (70%) + ependyma
• CSF absorbed: Arachnoid granulations → dural venous sinuses
• Total CSF volume: 150 mL (50 mL intracranial + 100 mL spinal)
• Any block in circulation or absorption → communicating or obstructive hydrocephalus → ↑ICP

2. Cerebral Blood Volume (CBV)

• Directly related to CBF
• CBV ↑ with: ↑PaCO₂, volatile agents, venous obstruction, prone positioning
• Most rapidly modifiable factor in acute ICP management

3. Brain Parenchyma Volume

• Oedema (vasogenic / cytotoxic), masses, haematoma

---

REGULATION OF ICP

Normal ICP (5-15 mmHg)
        │
        ├── Spatial compensation (CSF/venous displacement)
        ├── CO₂ reactivity (vasoconstriction → ↓CBV → ↓ICP)
        ├── Autoregulation (maintains CBF constant)
        └── CSF absorption ↑ when ICP rises (pressure-dependent)

---

EFFECT OF ANAESTHESIA ON ICP

Volatile Agents

• All volatile agents → cerebral vasodilation → ↑CBV → ↑ICP
• Halothane > Desflurane > Isoflurane > Sevoflurane (in degree of ICP elevation)
• Effect attenuated by prior hyperventilation (pre-treat with hyperventilation before volatile administration)

IV Agents

• Propofol, Thiopentone, Etomidate, Opioids → ↓CBF → ↓CBV → ↓ICP ✓
• Ketamine → ↑ICP (classic) — avoid in uncontrolled intracranial hypertension

Laryngoscopy & Intubation

• Stimulation → ↑MAP → ↑CBF → ↑ICP ("coughing spike")
• Attenuate with: Lidocaine 1.5 mg/kg IV 2 min before; fentanyl 2–3 µg/kg; beta-blocker (esmolol)

Positive Pressure Ventilation

• ↑PEEP → ↑intrathoracic pressure → ↓venous drainage → ↑CVP → ↑ICP
• Keep PEEP ≤5 cmH₂O in raised ICP cases; head 30° up; avoid neck compression

---

MANAGEMENT OF RAISED ICP — STEPWISE

TIER 1 (First Line):
├── Head elevation 30°, neutral neck position
├── Normoventilation → PaCO₂ 35–40 mmHg
├── Adequate sedation + analgesia (propofol ± opioid)
├── Normoglycaemia, normothermia
└── Treat precipitating cause

TIER 2 (If ICP >20 mmHg sustained):
├── Hyperventilation: PaCO₂ 30–35 mmHg (temporary bridge)
├── Mannitol 0.5–1 g/kg IV (20% solution, over 15–20 min)
├── Hypertonic saline 3% (1–2 mL/kg) — preferred if hyponatraemia
└── CSF drainage (EVD if in situ)

TIER 3 (Refractory):
├── Barbiturate coma (Thiopentone 3–5 mg/kg, then infusion)
├── Decompressive craniectomy
└── Therapeutic hypothermia (33–35°C)

---

QUICK SUMMARY — ICP

╔══════════════════════════════════════════════════════════╗
║ Normal ICP: 5–15 mmHg | Treat if >20 mmHg sustained    ║
║ Monroe-Kellie: Brain(80%) + CSF(10%) + Blood(10%) fixed ║
║ CPP = MAP − ICP | Target CPP 60–70 mmHg (BTF 2022)     ║
║ Fastest way to ↓ICP = hyperventilation (↓PaCO₂)        ║
║ Mannitol 0.5–1 g/kg = osmotic diuretic of choice        ║
║ Propofol/thiopentone = best IV agents for ↓ICP          ║
║ Sevoflurane = safest volatile (least ICP elevation)      ║
╚══════════════════════════════════════════════════════════╝

---

---

Q5 — CEREBRAL AUTOREGULATION + INHALATIONAL AGENTS

DEFINITION

"The brain protects itself from both underperfusion and hyperperfusion."

---

MECHANISM

↑CPP (↑MAP) → Cerebral arteriolar STRETCH
                    │
                    ▼
         Myogenic contraction (Bayliss effect)
                    │
                    ▼
         ↑Cerebrovascular Resistance (CVR)
                    │
                    ▼
         CBF remains CONSTANT ✓

↓CPP (↓MAP) → Reverse mechanism → vasodilation → ↑CVR↓ → CBF maintained

• Metabolic component: adenosine, CO₂, K⁺, H⁺ release modulating vascular tone
• Neurogenic component: sympathetic/parasympathetic fine-tuning

---

AUTOREGULATION CURVE

CBF (mL/100g/min)
    |
 75-|                    ___________
    |                   /           \
 50-|__________________/             \__________
    |                 /               \
 25-|                /                 \
    |_______________/                   \_______
    0      20    50                  150     200  CPP(mmHg)
                  ↑                   ↑
                Lower               Upper
                Limit               Limit

Impaired:  — — — (flat line lost, CBF = linear with CPP)

---

IMPLICATIONS OF INHALATIONAL AGENTS ON CEREBRAL AUTOREGULATION

Dose-dependent Impairment

Key Principle — MAC Dependency:

<0.5 MAC → Autoregulation largely INTACT
0.5–1 MAC → Partial impairment
>1 MAC → Autoregulation LOST
        → CBF becomes PRESSURE-PASSIVE
        → MAP ↓ → CBF ↓ → Ischaemia
        → MAP ↑ → CBF ↑ → Luxury perfusion, oedema

CO₂ Reactivity under Inhalational Agents:

• CO₂ reactivity is PRESERVED even when autoregulation is lost
• This is exploited clinically: hyperventilation still ↓CBF/ICP even during volatile anaesthesia
• Exception: extreme hyperventilation may cause paradoxical ischaemia

Clinical Implications:

• Use volatile agents at <1 MAC in neuro-anaesthesia
• Combine with TIVA (propofol) for cases with severely raised ICP
• Pre-treat with hyperventilation before introducing volatile agents
• Monitor CPP — do not allow MAP to fall below LLA (especially in hypertensives)

---

QUICK SUMMARY — CEREBRAL AUTOREGULATION

╔══════════════════════════════════════════════════════════════╗
║ Autoregulation: CPP 50–150 mmHg → CBF constant at 50      ║
║ Halothane abolishes it most; Sevoflurane impairs it least   ║
║ All volatiles impair autoregulation in DOSE-DEPENDENT way  ║
║ CO₂ reactivity PRESERVED even when autoregulation lost      ║
║ Hyperventilation remains effective ICP tool during GA      ║
║ >1 MAC → CBF becomes pressure-passive = DANGER zone        ║
╚══════════════════════════════════════════════════════════════╝

---

---

Q6 — BLOOD SUPPLY OF THE BRAIN + CEREBRAL PERFUSION PRESSURE (CPP)

BLOOD SUPPLY OF THE BRAIN

Arterial Supply — Two Systems

         BRAIN BLOOD SUPPLY
              │
    ┌─────────┴──────────┐
    │                    │
CAROTID SYSTEM       VERTEBROBASILAR SYSTEM
(Anterior 80%)       (Posterior 20%)
    │                    │
Internal Carotid A.  Vertebral A. (×2)
    │                    │
    ├─ Anterior           └─► Basilar A.
    │  Cerebral A.(ACA)          │
    │  → Frontal, medial         ├─ PICA (Cerebellum)
    │  surfaces                  ├─ AICA
    │                            ├─ Posterior Cerebral A. (PCA)
    └─ Middle                    │  → Occipital, temporal
       Cerebral A.(MCA)          └─ Pontine branches
       → Lateral cortex,
         internal capsule
         (MOST common
          stroke territory)

CIRCLE OF WILLIS (Anastomotic ring at base of brain)

              ACA (L) ——— ACoA ——— ACA (R)
               │                    │
              ICA (L)              ICA (R)
               │                    │
              MCA (L)             MCA (R)
               │                    │
              PCoA (L) ————— PCoA (R)
               │                    │
              PCA (L)——— Basilar ———PCA (R)
                              │
                         Vertebrals (×2)

Venous Drainage

• Cerebral veins → Dural venous sinuses (superior sagittal, transverse, sigmoid)
• → Internal jugular vein → Brachiocephalic → SVC
• No valves in cerebral venous system — position-dependent flow
• Obstruction (neck compression, head-down position) → venous congestion → ↑ICP

---

CEREBRAL PERFUSION PRESSURE (CPP)

• Normal CPP = 70–100 mmHg
• Minimum safe CPP = 50 mmHg (below this → ischaemia)
• Target CPP in head injury (BTF 2022): 60–70 mmHg

Factors Affecting CPP

CPP Management in Neuroanesthesia:

Target CPP = 60–70 mmHg
        │
        ├── Keep MAP ≥80 mmHg (use vasopressors if needed)
        ├── Keep ICP <20 mmHg (tiered ICP management)
        ├── Avoid PEEP >5 cmH₂O
        └── Head neutral, 30° elevation

---

---

Q7 — EFFECT OF ANAESTHETIC AGENTS ON THE DEVELOPING BRAIN

INTRODUCTION

---

WHY IS THE DEVELOPING BRAIN VULNERABLE?

Neonatal/Infant Brain (0–3 years):
        │
        ├── Rapid synaptogenesis (peak: 3rd trimester to 2 years)
        ├── Apoptosis (programmed cell death) ongoing
        ├── GABA is EXCITATORY (not inhibitory) — depolarizes neurons
        ├── NMDA receptors overexpressed (critical for synaptic pruning)
        └── Myelination incomplete until age 2–3 years

---

MECHANISMS OF NEUROTOXICITY

ANAESTHETIC EXPOSURE
(GABA agonists + NMDA antagonists)
           │
    ┌──────┴───────────┐
    ▼                  ▼
↑GABA inhibition   NMDA blockade
(apoptogenic in     (↓neurotrophic
developing brain)   factor BDNF, NGF)
    │                  │
    └──────┬───────────┘
           ▼
   Neuroapoptosis
   Synaptic pruning disruption
   Dendritic/axonal abnormality
           │
           ▼
   Cognitive, behavioural,
   memory impairment
   (demonstrated in animal models)

---

EVIDENCE — CLINICAL + ANIMAL

---

AGENTS OF CONCERN

---

ANAESTHETIC IMPLICATIONS & CLINICAL GUIDANCE

1. Delay elective surgery beyond age 3 years wherever possible
2. Single, short exposure (<1 hour) → current evidence suggests safe
3. Avoid multiple/repeated exposures in <3 years age group
4. Prefer regional anaesthesia as primary or adjunct technique
5. Use dexmedetomidine as co-induction/sedation — possibly neuroprotective
6. Inform parents (FDA SmartTots initiative — shared decision-making)
7. Avoid prolonged propofol infusion in young children → PRIS (Propofol Infusion Syndrome) risk

---

QUICK SUMMARY BOX

╔═══════════════════════════════════════════════════════════╗
║ FDA (2016): Warning — repeated GA in <3 yrs affects brain ║
║ PANDA & GAS trials: Single short exposure appears SAFE   ║
║ Most vulnerable: 0–3 years (peak synaptogenesis)         ║
║ Ketamine + volatiles → neuroapoptosis in animal models   ║
║ Dexmedetomidine → potentially neuroprotective            ║
║ Avoid elective surgery <3 yrs if possible                ║
║ Regional anaesthesia = preferred approach                 ║
╚═══════════════════════════════════════════════════════════╝

---

---

Q8 — ANATOMY OF THE SPINAL CORD + ANAESTHETIC SIGNIFICANCE

EXTENT

Spinal Cord:
├── Begins: Lower border of Medulla oblongata (Foramen magnum)
├── Ends:   L1–L2 in adults (Conus medullaris)
│           L3 in neonates/infants → descends with growth
├── Below conus: Cauda equina (nerve roots L2–S5)
└── Filum terminale: Fibrous prolongation, anchors to coccyx

---

LAYERS (COVERINGS)

Skin
  │
Supraspinous ligament
  │
Interspinous ligament
  │
Ligamentum flavum  ← Needle resistance felt here
  │
EPIDURAL SPACE     ← Epidural injection (fat, veins, lymphatics)
  │
DURA MATER         ← Tough outermost meningeal layer
  │
SUBDURAL SPACE     ← Potential space (unintended injection risk)
  │
ARACHNOID MATER    ← Delicate avascular membrane
  │
SUBARACHNOID SPACE ← Contains CSF (site of spinal anaesthesia)
  │
PIA MATER          ← Closely adherent to cord surface
  │
SPINAL CORD

---

CROSS-SECTIONAL ANATOMY

         POSTERIOR (Dorsal)
              │
    Dorsal Columns         ← Proprioception, vibration, fine touch
    (Gracile + Cuneate)    (Ipsilateral)
              │
  ┌───────────┴────────────┐
  │    Grey Matter (H)     │
  │   ┌────────────────┐   │
  │   │ Dorsal Horn    │◄──┼── Sensory input (pain, temp)
  │   │ (Afferent)     │   │
  │   ├────────────────┤   │
  │   │ Lateral Horn   │◄──┼── Sympathetic preganglionic (T1–L2)
  │   │ (Autonomic)    │   │
  │   ├────────────────┤   │
  │   │ Ventral Horn   │──►┼── Motor output (LMN)
  │   │ (Efferent)     │   │
  │   └────────────────┘   │
  └───────────┬────────────┘
              │
    Lateral Spinothalamic   ← Pain, temperature (contralateral, crosses
    Tract                     1–2 levels above entry → Anatomy of
                              epidural/intrathecal analgesia spread)
              │
         ANTERIOR (Ventral)

---

ROOTS

---

MAIN DIVISIONS / TRACTS

---

SYMPATHETIC CHAIN

Preganglionic sympathetic fibres:
Origin: Lateral horn, T1 → L2 (Thoracolumbar outflow)
        │
        ▼
Paravertebral sympathetic chain (paired, bilateral)
        │
        ├── Cervical ganglia (Superior, Middle, Stellate/Inferior)
        ├── Thoracic ganglia (T1–T12)
        ├── Lumbar ganglia
        └── Sacral ganglia
        │
        ▼
Postganglionic fibres → target organs

• Spinal/Epidural anaesthesia → blocks sympathetic preganglionic fibres → vasodilation, hypotension, bradycardia
• Level of sympathetic block 2–6 dermatomes HIGHER than sensory block
• T1–T4 block → Cardiac accelerator fibres blocked → bradycardia (Bezold–Jarisch)
• Stellate ganglion block → Horner's syndrome (ptosis, miosis, anhidrosis)
• Coeliac plexus block (T12–L1) → visceral pain relief (pancreatic cancer)

---

BLOOD SUPPLY OF SPINAL CORD

ANTERIOR SPINAL ARTERY (1) ← Vertebral arteries + Adamkiewicz
→ Supplies anterior 2/3 of cord (motor + autonomic)
→ VULNERABLE to ischaemia (watershed zone)

POSTERIOR SPINAL ARTERIES (2) ← PICA
→ Supply posterior 1/3 (sensory)

Artery of Adamkiewicz:
→ Major anterior radicular artery
→ Usually LEFT side, T9–L2
→ At risk in aortic surgery (cross-clamping)
→ Anterior spinal artery syndrome: paraplegia + loss of pain/temp,
  proprioception PRESERVED (posterior spared)

---

ANAESTHETIC SIGNIFICANCE — CONSOLIDATED TABLE

---

QUICK SUMMARY — SPINAL CORD ANATOMY

╔═══════════════════════════════════════════════════════════╗
║ MNEMONIC: "DAPS" = Dura → Arachnoid → Pia → Spinal cord ║
╠═══════════════════════════════════════════════════════════╣
║ Cord ends: L1–L2 adult | L3 neonates                     ║
║ LP: L3–L4 or L4–L5 (adults); L4–L5 (infants)            ║
║ Sympathetic: T1–L2 (lateral horn)                        ║
║ Sympathetic block 2–6 levels higher than sensory         ║
║ T1–T4 block → cardiac accelerators blocked → bradycardia ║
║ LOR = needle through ligamentum flavum into epidural      ║
║ Artery of Adamkiewicz (T9–L2, usually left) → aortic Sx  ║
║ Anterior 2/3 (ASA) = motor; Posterior 1/3 (PSA) = sensory║
╚═══════════════════════════════════════════════════════════╝

---

MASTER REVISION SUMMARY — ALL 8 QUESTIONS

---

Questions Covered & Their Overlap

---

High-Yield Examiner Tips for This Module

1. Q1/Q2 (CBF) — Always draw the PaCO₂ vs CBF graph and the autoregulation curve. Examiners award marks for these visuals.
2. Q3/Q4 (ICP) — Monroe-Kellie doctrine + tiered management flowchart are essential. Mention BTF Guidelines 2022 for scoring recent advances marks.
3. Q5 (Autoregulation) — The phrase "CO₂ reactivity is preserved even when autoregulation is lost" is a high-yield viva pearl that consistently earns marks.
4. Q6 (CPP) — The formula CPP = MAP − ICP must appear in first line. Circle of Willis diagram earns diagram marks quickly.
5. Q7 (Developing brain) — FDA 2016 + PANDA trial + GAS trial are the three references that immediately signal to the examiner you are reading current literature.
6. Q8 (Spinal cord) — The Artery of Adamkiewicz and its clinical relevance to aortic surgery is consistently tested in viva and theory.

---

NEUROMUSCULAR PHYSIOLOGY — DNB FINAL ANAESTHESIA

Complete Answers (Questions 1–7)

---

Note on overlaps: Q1, Q2, Q4a, Q5a, and Q7 all ask about NMJ/neuromuscular transmission. These share a common core answer. Q2 adds cholinesterase inhibitors. Q3 focuses on ACh receptor structure. Q4b covers factors influencing transmission. Q5b covers NMB types. Q5c covers Phase II block. Q6 covers cholinesterases in detail.

---

Q1, Q2, Q4a, Q5a, Q7 — NEUROMUSCULAR JUNCTION (NMJ) & NEUROMUSCULAR TRANSMISSION

1. INTRODUCTION

• Each motor neuron innervates 3 to several hundred skeletal muscle fibres (motor unit)
• Junction formed at the midpoint of each muscle fibre
• ~2% of fibres have multiple junctions; rest have one

---

2. ANATOMY OF THE NMJ — LABELLED DIAGRAM

        MYELINATED MOTOR NERVE AXON
                 │
                 │  Myelin sheath ends
                 ▼
        ┌────────────────────┐
        │  AXON TERMINAL     │  (Presynaptic)
        │  (Bouton/Knob)     │
        │  ┌──────────────┐  │
        │  │ Mitochondria │  │ ← ATP synthesis
        │  │ ACh vesicles │  │ ← ~300,000 vesicles
        │  │ (Quanta)     │  │   each = ~10,000 ACh molecules
        │  │ Ca²⁺ channels│  │ ← Voltage-gated (N-type)
        │  └──────────────┘  │
        └────────────────────┘
                 │
          SYNAPTIC CLEFT (20–30 nm)
          contains AChE (acetylcholinesterase)
                 │
        ┌────────────────────┐
        │  MOTOR END PLATE   │  (Postsynaptic)
        │  (Muscle Membrane) │
        │  ┌──────────────┐  │
        │  │ Junctional   │  │ ← Nicotinic ACh receptors (nAChR)
        │  │ folds /      │  │   concentrated here
        │  │ subneural    │  │
        │  │ clefts       │  │ ← ↑surface area for ACh binding
        │  └──────────────┘  │
        └────────────────────┘
                 │
          MUSCLE FIBRE

---

3. PHYSIOLOGY OF NEUROMUSCULAR TRANSMISSION — STEP-BY-STEP

STEP 1: ACTION POTENTIAL arrives at motor nerve terminal
                 │
                 ▼
STEP 2: Voltage-gated Ca²⁺ channels (N-type/P/Q-type) OPEN
        Ca²⁺ influx into presynaptic terminal
                 │
                 ▼
STEP 3: Ca²⁺ activates calmodulin-dependent protein kinase
        → Phosphorylates SYNAPSIN proteins
        → Releases ACh vesicles from cytoskeleton anchorage
                 │
                 ▼
STEP 4: Vesicles DOCK at active zones (dense bars)
        → SNARE complex (VAMP, Syntaxin, SNAP-25) facilitates
        → EXOCYTOSIS — ~125 vesicles released per impulse
        → Quantum of ACh released into synaptic cleft
                 │
                 ▼
STEP 5: ACh diffuses across 20–30 nm synaptic cleft
                 │
                 ▼
STEP 6: ACh binds to NICOTINIC ACh RECEPTORS (nAChR) on motor end plate
        → 2 ACh molecules must bind (α subunits)
        → Ion channel OPENS: Na⁺ in, K⁺ out (net Na⁺ influx)
        → END PLATE POTENTIAL (EPP) generated
                 │
                 ▼
STEP 7: EPP depolarizes muscle membrane
        → If EPP > threshold → ACTION POTENTIAL propagates
        → Propagates bidirectionally along muscle fibre
                 │
                 ▼
STEP 8: Action potential → T-tubule system
        → Sarcoplasmic reticulum Ca²⁺ release
        → Actin-Myosin cross-bridge formation → CONTRACTION
                 │
                 ▼
STEP 9: ACh rapidly hydrolysed by AChE (within milliseconds)
        → Acetate + Choline
        → Choline taken back up by presynaptic terminal
        → Re-synthesized into ACh by choline acetyltransferase (ChAT)
        → Recycled into vesicles

---

3. ACh RECEPTOR (nAChR) — STRUCTURE (Q3)

Structure

NICOTINIC ACh RECEPTOR — Ligand-Gated Ion Channel
(Pentameric glycoprotein — 5 subunits)

         EXTRACELLULAR
              │
    ┌─────────┴──────────────┐
    │  α  β  δ  ε  α         │
    │  ↑           ↑         │
    │  ACh         ACh       │ ← Both α-subunits bind ACh
    │  binding     binding   │
    │  site        site      │
    │                        │
    │   ION CHANNEL PORE     │
    │   (Central lumen)      │
    │   Na⁺ in / K⁺ out      │
    └────────────────────────┘
              │
         INTRACELLULAR

Key: Two ACh molecules must bind simultaneously to BOTH α-subunits to open the channel — explains why competitive antagonists need only occupy one α-subunit to block transmission (safety factor concept).

Changes when ACh Binds:

RESTING STATE (Channel CLOSED)
         │
         │ 2× ACh binds to both α subunits
         ▼
ACTIVATED STATE (Channel OPEN) — 1–2 ms
         │ Na⁺ influx, K⁺ efflux
         │ EPP generated
         │
         │ ACh rapidly hydrolysed by AChE
         ▼
RESTING STATE restored (Channel CLOSES)

Prolonged occupation of α-subunits
         │
         ▼
DESENSITISED STATE (Channel CLOSED even with agonist)
→ Receptor conformationally altered — refractory
→ Basis of Phase II block (depolarizing agents)

---

4. FACTORS INFLUENCING NEUROMUSCULAR TRANSMISSION (Q4b)

A. Physiological Factors

B. Drug Interactions

C. Disease States

---

5. TYPES OF NEUROMUSCULAR BLOCKING AGENTS (Q5b)

NEUROMUSCULAR BLOCKING AGENTS (NMBAs)
                │
    ┌───────────┴──────────────┐
    │                          │
DEPOLARISING              NON-DEPOLARISING (Competitive)
    │                          │
Succinylcholine           ┌────┴────────┐
(Suxamethonium)      Steroidal    Benzylisoquinolinium
                          │                │
                    ├─Rocuronium    ├─Atracurium
                    ├─Vecuronium    ├─Cisatracurium
                    ├─Pancuronium   └─d-Tubocurarine
                    └─Pipecuronium    (historic)

Comparison Table

---

6. PHASE II BLOCK (Q5c)

Definition

Mechanism

Succinylcholine (Phase I block)
Persistent α-subunit occupation
             │
             ▼
Initial depolarisation (fasciculations)
             │
             ▼  [With prolonged/repeated doses >3–5 mg/kg cumulative]
             ▼
Receptor DESENSITISATION
→ Receptor undergoes conformational change
→ Remains CLOSED despite continued agonist binding
→ End plate becomes INSENSITIVE to further depolarisation
             │
             ▼
PHASE II BLOCK — channel closed, agonist still bound
→ Resembles non-depolarising block profile

Distinguishing Features

Factors Facilitating Phase II Block

• Large cumulative succinylcholine dose (>3–5 mg/kg)
• Infusion >30 min
• Volatile anaesthesia
• Hypokalaemia, hypothermia
• Pre-existing neuromuscular disease

Clinical Management

Suspected Phase II Block
         │
         ▼
Confirm with TOF (fade present?)
         │
    ┌────┴──────────┐
    YES (Fade)      NO (No fade) → Still Phase I
    │
    ▼
STOP succinylcholine
Allow spontaneous recovery
    │
    ▼
If no recovery in 20–30 min:
→ Trial of Neostigmine 0.04–0.07 mg/kg
  + Glycopyrrolate 0.01 mg/kg
→ Monitor TOF response
→ If deterioration → stop neostigmine → ventilate
    │
    ▼
ICU ventilation if persistent block
Measure pseudocholinesterase levels

---

7. CHOLINESTERASES — TYPES, ROLE, CONDITIONS WHERE REDUCED (Q6)

Types of Cholinesterase

Role of AChE at NMJ

ACh released into synaptic cleft
             │
             ▼
ACh binds nAChR → EPP → contraction
             │
             ▼  (within 1–2 ms)
AChE (in synaptic cleft) hydrolyses ACh
→ Acetate + Choline
             │
             ▼
Choline reuptaken by presynaptic terminal (high-affinity choline transporter)
→ Re-synthesized to ACh by choline acetyltransferase (ChAT)
→ Refilled into vesicles
             │
             ▼
NMJ RESET — ready for next impulse

Conditions Where Pseudocholinesterase is REDUCED

Genetic Variants of Pseudocholinesterase

Dibucaine Number = % inhibition of pseudocholinesterase by 10⁻⁵ M dibucaine. Lower number = abnormal enzyme = prolonged succinylcholine effect.

• Succinylcholine apnoea in homozygous patients → ventilate, sedate in ICU until spontaneous recovery
• Send serum for pseudocholinesterase level + dibucaine number
• Warn patient + family (autosomal recessive inheritance)
• Mivacurium also prolonged in these patients

---

8. CHOLINESTERASE INHIBITORS (ANTICHOLINESTERASES) — Q2 & Q6

Commonly Used Agents

NEOSTIGMINE — In Detail

Neostigmine binds reversibly to AChE at NMJ
         │
         ▼
AChE temporarily INHIBITED (carbamylation of esteratic site)
         │
         ▼
ACh accumulates in synaptic cleft (not hydrolysed)
         │
         ▼
↑ACh → Displaces residual NDMR from α-subunits (competitive displacement)
         │
         ▼
REVERSAL of non-depolarising neuromuscular block

• Onset: 3–5 min; Peak: 7–11 min; Duration: 20–30 min
• Does NOT cross BBB (quaternary amine)
• Metabolized by plasma cholinesterase and liver; partially excreted renally

DUMBELS:
D — Defecation, Diarrhoea
U — Urination
M — Miosis
B — Bradycardia, Bronchospasm, Bronchorrhoea
E — Emesis
L — Lacrimation
S — Salivation

• Asthma / Bronchospasm (↑secretions, bronchospasm)
• Deep block (TOF count 0–1) — inadequate reversal, paradoxical worsening
• Phase II block — unpredictable effect
• Bradyarrhythmias (worsens bradycardia)

Reversal — When is TOF adequate for neostigmine?

TOF Count:
0–1 → DO NOT use neostigmine (inadequate, may deepen block)
2–3 → Use with caution (train-of-four count must be ≥2)
4 with fade → Neostigmine effective
4 without fade (TOF ratio ≥0.9) → Full recovery; neostigmine not needed

SUGAMMADEX (Org 25969) — Selective relaxant binding agent:

• Encapsulates rocuronium/vecuronium (steroidal NMBAs) directly
• Does NOT work on benzylisoquinoliniums or succinylcholine
• No muscarinic effects → no need for anticholinergic
• Dose: 2 mg/kg (TOF count 2+), 4 mg/kg (TOF count 1–2), 16 mg/kg (immediate reversal of rocuronium)
• Guideline: ESAIC 2023 — sugammadex preferred over neostigmine for routine reversal

---

QUICK REVISION SUMMARY BOX — NMJ PHYSIOLOGY

╔══════════════════════════════════════════════════════════════════╗
║              NMJ — HIGH-YIELD VIVA PEARLS                       ║
╠══════════════════════════════════════════════════════════════════╣
║ MNEMONIC for ACh release: "Ca DOCKS ACh"                        ║
║ Ca²⁺ → calmodulin → synapsin phosphorylation → SNARE →         ║
║ exocytosis → 125 vesicles/impulse → each ~10,000 ACh molecules  ║
╠══════════════════════════════════════════════════════════════════╣
║ • Synaptic cleft = 20–30 nm wide                                ║
║ • 2 ACh molecules needed to open ONE nAChR channel              ║
║ • Adult nAChR = α₂βεδ (59 pS); Fetal = α₂βγδ (40 pS)          ║
║ • AChE hydrolysis: 1 molecule ACh per millisecond               ║
║ • Succinylcholine: ONLY Phase I at low dose; Phase II at >3mg/kg║
║ • Phase II = TOF fade + post-tetanic facilitation               ║
║ • Neostigmine MUST always be paired with glycopyrrolate          ║
║ • Dibucaine number: Normal=80, Heterozygous=60, Homozygous=20   ║
║ • Mg²⁺ competes with Ca²⁺ → potentiates NMB → magnesium toxicity║
║ • Burns/denervation → extrajunctional receptors → K⁺ storm      ║
║ • Sugammadex: only reverses steroidal NMBAs (roc/vec)           ║
╠══════════════════════════════════════════════════════════════════╣
║ COMMON MISTAKES TO AVOID:                                        ║
║ ✗ Giving neostigmine with TOF count 0–1                          ║
║ ✗ Using succinylcholine in burns >48 hrs / denervation           ║
║ ✗ Forgetting glycopyrrolate with neostigmine                     ║
║ ✗ Expecting sugammadex to reverse succinylcholine                ║
╚══════════════════════════════════════════════════════════════════╝

---

MASTER SUMMARY TABLE — ALL 7 QUESTIONS

---

ANAESTHESIA MACHINE — SAFETY FEATURES & PREVENTION OF HYPOXIC GAS MIXTURE DELIVERY

DNB Final Anaesthesia | Distinction-Level Answer

---

Questions covered (all identical in core content):

• Safety features in modern anaesthesia machines (Dec 2010, June 2012, June 2013, Dec 2016)
• Features that prevent delivery of hypoxic gas mixtures (Dec 2011, June 2012, June 2013, Dec 2016)
• Various safety features incorporated in modern-day anaesthesia machines

---

1. INTRODUCTION

PIPELINE/CYLINDER → PRESSURE REGULATION → FLOWMETERS
→ VAPORISER → BREATHING CIRCUIT → PATIENT
     ↑
Safety devices at EACH stage

---

2. CLASSIFICATION OF SAFETY FEATURES

SAFETY FEATURES OF MODERN ANAESTHESIA MACHINE
                    │
    ┌───────────────┼────────────────────┐
    ▼               ▼                    ▼
Gas Supply      Flow Control &        Breathing Circuit
Level           Hypoxic Prevention    & Ventilator
    │               │                    │
    ▼               ▼                    ▼
Pin Index       Link-25 / ORMC      Low airway pressure
PISS            O₂ flowmeter         alarm
Colour coding   downstream           CO₂ absorber
O₂ fail alarm   O₂ analyser          APL valve
Check valve     Min O₂ ratio         Disconnect alarm
                                     Oxygen flush

---

3. GAS SUPPLY SAFETY FEATURES

A. Pin Index Safety System (PISS) — Cylinder Supply

Each cylinder yoke has PINS in specific positions:
         O₂  →  Pins at  2 and 5
         N₂O →  Pins at  3 and 5
         Air →  Pins at  1 and 5
         CO₂ →  Pins at  1 and 6

Corresponding HOLES on cylinder valve match ONLY that gas
→ WRONG cylinder CANNOT be connected to wrong yoke

• Prevents connection of wrong gas cylinder to machine
• Mandated by BSI and ISO standards
• Fails if: pins are removed, adapters used, or >1 washer

B. Pipeline Inlet Safety System (PISS / Diameter Index Safety System — DISS)

• Pipeline hoses have specific non-interchangeable connectors (DISS — Diameter Index Safety System) for each gas
• Each pipeline probe has a unique diameter — wrong gas hose cannot connect to wrong pipeline inlet
• Colour coding: O₂ = White (International/ISO), N₂O = Blue, Air = Black/White (varies by region)
• In India: O₂ = Black with white shoulder (per BIS); N₂O = Blue

C. Colour Coding (International ISO 32 Standard)

D. Pressure Gauges

• Each gas has an independent pressure gauge on the machine
• Allows immediate visual verification of gas supply pressure

E. One-Way (Check) Valves

• Located between cylinder and pipeline inlets
• Prevent backflow of gas from pipeline into empty cylinders
• Prevent gas from one cylinder entering another

---

4. OXYGEN PRESSURE FAILURE DEVICES — CRITICAL SAFETY FEATURES

A. O₂ Pressure Failure Alarm (Oxygen Failure Warning Device — OFWD)

O₂ PIPELINE PRESSURE FALLS BELOW THRESHOLD (~30 psig)
                │
                ▼
AUDIBLE ALARM ACTIVATES — whistling/beeping sound
(Minimum 7 seconds duration — ASTM standard)
                │
                ▼
If pressure continues to fall:
→ O₂ pressure-driven safety interlock activates
→ N₂O and other gas flows AUTOMATICALLY CUT OFF
→ Prevents delivery of pure N₂O to patient

• Devices: Ritchie Whistle (pneumatic — no electrical power needed)
• Alarm triggered: O₂ pressure <30 psi (typically)
• Must be pressure-driven (pneumatic) — not dependent on electricity

B. O₂ Failure Cutoff Valve (Hypoxic Guard / N₂O Cutoff)

• When O₂ fails → pneumatic signal cuts off N₂O supply valve
• N₂O flow goes to ZERO when O₂ pressure fails
• This is the primary protection against pure N₂O delivery

---

5. HYPOXIC GAS MIXTURE PREVENTION DEVICES (MOST IMPORTANT SECTION)

A. Link-25 Proportioning System (Ohmeda/GE Machines)

MECHANISM (Mechanical Chain-Link System):

O₂ flow control sprocket (14 teeth)
         │
         │← Mechanical chain link
         │
N₂O flow control sprocket (29 teeth)
         │
         ▼
When N₂O flow is increased:
→ Chain link rotates O₂ sprocket
→ FORCES O₂ flow to increase proportionally
→ MINIMUM O₂ concentration maintained ≥25%

Gear ratio 14:29 = ensures N₂O:O₂ ratio ≤3:1
(i.e., minimum 25% O₂ in N₂O+O₂ mixture)

• Operates mechanically (pneumatic) — independent of electricity
• Prevents N₂O:O₂ ratio from exceeding 3:1
• Does NOT protect against: third gas (helium, air) dilution, wrong pipeline supply

B. Sensitive Oxygen Ratio Monitor Controller (S-ORC) — Dräger Machines

MECHANISM (Pneumatic):

O₂ pressure from pipeline feeds into S-ORC pneumatic controller
         │
         ▼
S-ORC valve is a pressure-operated gate on N₂O supply line
         │
         ▼
↓ O₂ pressure → S-ORC valve restricts N₂O flow
→ Ensures minimum O₂:N₂O ratio maintained (≥25% O₂)

• Uses differential pressure between O₂ and N₂O to govern N₂O flow
• Analogous function to Link-25 but pneumatic (not mechanical chain)
• Standard on Dräger Fabius, Apollo workstations

C. Oxygen Ratio Monitor Controller (ORMC) — General Principle

D. Position of O₂ Flowmeter Tube — Downstream Safety

FLOWMETER ARRANGEMENT (Left to Right):
N₂O → Air → O₂ (rightmost, closest to common manifold outlet)
                │
                ▼
If O₂ tube CRACKS or LEAKS:
→ O₂ leaks INTO common gas flow (not away from patient)
→ Mixture becomes MORE oxygenated, not hypoxic
→ Safety by POSITION

• O₂ flowmeter must always be placed DOWNSTREAM (rightmost) — mandatory by ASTM standard
• This single design feature prevents an O₂ tube crack from causing hypoxia

E. Minimum O₂ Flow / Basal O₂ Flow

• Many machines have a fixed minimum O₂ flow of 150–250 mL/min that cannot be turned below a threshold
• Prevents accidental zero O₂ flow

F. O₂ Flush Button

• Delivers 100% O₂ at 35–75 L/min directly to common gas outlet
• Bypasses flowmeters and vaporisers
• Immediately corrects hypoxia
• MUST be used cautiously — risk of barotrauma if circuit is closed; delivers 100% O₂ undiluted

---

6. FLOW CONTROL KNOB SAFETY FEATURES

O₂ Flow Control Knob distinguishable by:
├── FLUTED (ribbed) texture (others are smooth)
├── Largest diameter of all knobs
├── Projects FURTHEST beyond panel
├── Colour-coded (GREEN internationally)
├── Permanently labelled "O₂" or chemical formula
└── Recessed with guard/barrier → prevents accidental turn

→ By TOUCH alone, operator can identify O₂ knob in dark

---

7. VAPORISER SAFETY FEATURES

A. Selectatec / Interlock System

Multiple vaporiser back-bar system:
→ Only ONE vaporiser can be ON at a time
→ Mechanical interlock prevents two vaporisers being selected simultaneously
→ Prevents accidental delivery of TWO volatile agents

B. Keyed Filling Devices (Agent-Specific Filling)

• Each volatile agent has a colour-coded, agent-specific filling adaptor
• Prevents filling wrong agent into vaporiser

C. Tipping Lock

• Vaporisers have a locking mechanism that prevents use after tipping
• Tipping → liquid agent enters bypass chamber → massive overdose if used immediately
• Must be upright and allowed to equilibrate before use

D. Temperature Compensation

• Vaporiser output remains constant despite temperature changes (bimetallic strip)
• Prevents overdose in warm environments

---

8. BREATHING CIRCUIT SAFETY FEATURES

A. Low Airway Pressure / Disconnect Alarm

• Triggers if circuit pressure fails to reach threshold during IPPV
• Most common alarm in practice
• Detects: breathing circuit disconnection, ETT disconnection, circuit leak

B. High Airway Pressure Alarm

• Triggers if circuit pressure exceeds set limit (typically 40 cmH₂O)
• Protects lungs from barotrauma

C. Apnoea Alarm

• If no breath is detected within set interval (usually 15–20 sec)
• Triggers when spontaneous or mechanical breathing ceases

D. O₂ Analyser / Paramagnetic O₂ Monitor

Location: Downstream of vaporiser, within breathing circuit
→ Continuously measures FiO₂ ACTUALLY delivered to patient
→ Alarms if FiO₂ falls below preset minimum (typically 0.18–0.21)
→ LAST LINE OF DEFENCE against hypoxic mixture delivery
→ GOLD STANDARD protection device

• Uses paramagnetic principle (O₂ is paramagnetic) or fuel-cell (Clark electrode)
• Must be calibrated to 21% (room air) and 100% O₂ before each use

E. Adjustable Pressure Limiting (APL) Valve

• Prevents excessive pressure build-up in circuit (pop-off valve)
• Set to appropriate level based on circuit mode

F. Unidirectional Valves (Circle System)

• Inspiratory and expiratory unidirectional valves
• Prevent rebreathing of exhaled gas
• Ensure CO₂ passes through soda lime absorber

G. CO₂ Absorber (Soda Lime/Amsorb)

• Absorbs CO₂ from rebreathed gas
• Colour indicator changes when exhausted (white → purple/violet)
• Prevents CO₂ rebreathing and hypercapnia

H. Tidal Volume / Minute Volume Monitor

• Integrated spirometry
• Alarms for low or high tidal volume delivery

---

9. ELECTRICAL / ELECTRONIC SAFETY FEATURES (MODERN WORKSTATIONS)

---

10. PRE-USE MACHINE CHECK — SAFETY FRAMEWORK

BEFORE EVERY LIST:
1. Check O₂ supply (cylinder + pipeline pressure)
2. Check N₂O, Air supply
3. Leak test (negative pressure test / positive pressure test)
4. Flow control — confirm O₂ flows freely
5. Vaporiser check — filled, tipped-lock, selectatec
6. O₂ analyser calibration (21% and 100%)
7. Breathing circuit — integrity check
8. CO₂ absorber — colour check
9. Ventilator check
10. Monitoring alarms — set and functional
11. Suction, airway equipment, emergency drugs — checked

---

11. SUMMARY TABLE — ALL SAFETY FEATURES CATEGORISED

---

QUICK REVISION SUMMARY BOX

╔══════════════════════════════════════════════════════════════════╗
║    SAFETY FEATURES — HIGH-YIELD VIVA PEARLS                     ║
╠══════════════════════════════════════════════════════════════════╣
║ MNEMONIC for Hypoxic Guard devices: "LOSS"                      ║
║ L — Link-25 (Ohmeda/GE)                                         ║
║ O — O₂ failure cutoff (N₂O shut-off valve)                     ║
║ S — S-ORC (Dräger)                                              ║
║ S — Sensor (O₂ analyser — LAST line of defence)                 ║
╠══════════════════════════════════════════════════════════════════╣
║ • PISS: O₂ = pins 2+5; N₂O = pins 3+5; Air = pins 1+5          ║
║ • O₂ flowmeter MUST be rightmost (downstream) — ASTM mandatory  ║
║ • Link-25 ensures minimum 25% O₂ in N₂O+O₂ mixture             ║
║ • O₂ knob = FLUTED, largest, projects furthest                  ║
║ • Ritchie whistle: sounds ≥7 seconds on O₂ failure              ║
║ • O₂ analyser = LAST LINE OF DEFENCE (placed in circuit)        ║
║ • Selectatec prevents 2 vaporisers ON simultaneously            ║
║ • Keyed filler = agent-specific, colour-coded filling           ║
║ • Tipping lock: do not use vaporiser immediately after tipping  ║
║ • Pre-use check: FDA 2008 / AAGBI 2012 checklist mandatory      ║
╠══════════════════════════════════════════════════════════════════╣
║ COMMON MISTAKES TO AVOID:                                        ║
║ ✗ Placing O₂ flowmeter upstream (WRONG — must be downstream)    ║
║ ✗ Thinking Link-25 protects against 3rd-gas dilution (it doesn't)║
║ ✗ Forgetting O₂ analyser calibration before list               ║
║ ✗ Using vaporiser immediately after tipping                     ║
║ ✗ Confusing PISS (cylinders) vs DISS (pipelines)               ║
╚══════════════════════════════════════════════════════════════════╝

---

---

SAFETY FEATURES IN MODERN DAY ANAESTHESIA MACHINE

DNB Final Anaesthesia | 10-Mark Distinction-Level Answer

---

1. INTRODUCTION

HOSPITAL GAS SUPPLY
       │
       ▼
HIGH-PRESSURE SECTION
(Cylinders + Pipelines + Regulators)
       │
       ▼
INTERMEDIATE-PRESSURE SECTION
(Flowmeters + Proportioning systems)
       │
       ▼
LOW-PRESSURE SECTION
(Vaporisers + Common gas outlet)
       │
       ▼
BREATHING CIRCUIT & VENTILATOR
       │
       ▼
PATIENT

• ASTM F1850-00 (USA — Anaesthesia workstation standard)
• ISO 80601-2-13:2011 (International)
• BIS 7885 (India)

---

2. CLASSIFICATION OF ALL SAFETY FEATURES

SAFETY FEATURES
        │
  ┌─────┼──────────────────────────┐
  ▼     ▼                          ▼
GAS    HYPOXIA                BREATHING
SUPPLY PREVENTION             CIRCUIT
SAFETY DEVICES                SAFETY
  │     │                          │
  ▼     ▼                          ▼
PISS  Link-25               Disconnect alarm
DISS  S-ORC                 O₂ analyser
Colour O₂ fail alarm        High/Low P alarm
coding O₂ downstream FMT    APL valve
Regs   Min O₂ flow          CO₂ absorber
Check  O₂ flush             Spirometry
valves                       Ventilator alarms

---

3. HIGH-PRESSURE SECTION SAFETY FEATURES

A. Pin Index Safety System (PISS) — Cylinder Supply

YOKE ASSEMBLY has 2 METAL PINS in GAS-SPECIFIC positions:

Gas          Pin Positions
──────────────────────────
O₂        →  2 and 5
N₂O       →  3 and 5
Air       →  1 and 5
CO₂       →  1 and 6
Cyclopropane → 3 and 6
He/O₂     →  2 and 4

Cylinder valve has matching HOLES — only correct cylinder fits
→ Wrong cylinder PHYSICALLY CANNOT be mounted

• Hanger yoke also has a Bodok seal (non-interchangeable washer) ensuring gas-tight fit
• A filter traps particulate matter from cylinder gas
• A unidirectional check valve in double-yoke assemblies:
  • Prevents gas transfer from full to empty cylinder
  • Prevents gas escaping from open yoke (no cylinder mounted)
  • Ensures machine draws from pipeline, not cylinder, during normal operation

Critical principle: E-cylinder regulator output (~40–45 psig) is set below pipeline pressure (50–55 psig) → machine preferentially uses pipeline supply, preserving cylinder for emergencies. If pipeline fails, cylinder automatically takes over. (Miller's 10e, Barash 9e)

• Fails if pins are forcibly removed
• Fails if >1 washer (Bodok seal) is used
• CO₂/O₂ mixtures (>7% CO₂) share the same pin arrangement as CO₂ alone

---

B. Diameter Index Safety System (DISS) — Pipeline Supply

Each pipeline gas has a UNIQUE non-interchangeable wall outlet
and machine inlet connector with a SPECIFIC diameter:

O₂ pipeline hose   ──X──  N₂O pipeline inlet
(different diameter → physically impossible to connect)

Connectors are: THREADED + UNIQUE DIAMETER per gas
→ No two different gas hoses can be cross-connected

---

C. Colour Coding

Note: There is no FDA standard for cylinder colour in the USA — reading the label is always mandatory regardless of colour.

---

D. Pressure Gauges

• Each gas has an independent, dedicated pressure gauge visible on the machine front
• Allows immediate verification of pipeline and cylinder supply pressures
• Pipeline pressure should read 400 kPa (≈50–55 psig) for all gases

---

4. OXYGEN SUPPLY FAILURE SAFETY SYSTEMS (Q7 — Dec 2021)

A. Oxygen Pressure Failure Alarm (OFWD — Oxygen Failure Warning Device)

O₂ PIPELINE PRESSURE FALLS BELOW THRESHOLD
(typically <200 kPa / ~30 psig)
              │
              ▼
AUDIBLE ALARM ACTIVATES
(Minimum duration: 7 seconds — ASTM F1850)
("Ritchie Whistle" — pneumatically driven,
 works WITHOUT electrical power)
              │
              ▼
If pressure continues to fall:
→ O₂ FAILURE CUTOFF VALVE activates
→ N₂O and all other gas flows AUTOMATICALLY SHUT OFF
→ Room air (or reservoir bag) admitted in some designs
→ Prevents delivery of pure N₂O or hypoxic mixture

• Operates using stored O₂ pressure — independent of electricity
• This is critical: failure may occur during power outage
• Whistle sounds as O₂ pressure drops → before patient is harmed

B. O₂ Failure Cutoff Valve (N₂O Interlock / Hypoxic Guard Interlock)

O₂ pressure drops
       │
       ▼
Pneumatic signal to N₂O supply valve
       │
       ▼
N₂O supply valve CLOSES (spring-loaded, fail-safe design)
       │
       ▼
N₂O flow = ZERO
→ Cannot deliver pure N₂O if O₂ absent

• Present on ALL modern anaesthesia machines
• Works in conjunction with proportioning systems

---

5. HYPOXIA PREVENTION SAFETY DEVICES (Q2, Q3, Q4 — MOST IMPORTANT)

A. Link-25 Proportioning System (Ohmeda / GE Datex machines)

MECHANICAL CHAIN-LINK SYSTEM:

O₂ flow control valve ←──────────┐
    (Sprocket: 14 teeth)         │ Chain
                                  │
N₂O flow control valve ──────────┘
    (Sprocket: 29 teeth)

GEAR RATIO: 29:14 ≈ 2.07:1

When operator increases N₂O flow:
→ Chain ROTATES O₂ sprocket
→ FORCES O₂ to increase automatically
→ Minimum O₂ concentration maintained = 25%
   (N₂O:O₂ ratio capped at 3:1)

When operator decreases O₂ flow:
→ N₂O flow automatically REDUCED
→ O₂% never falls below 25%

• Entirely mechanical/pneumatic — no electricity required
• Only operates on N₂O + O₂ mixture — does NOT protect against dilution with a third gas (e.g., He, Air)
• Does NOT protect against crossed pipelines (if N₂O is in O₂ pipeline)
• Minimum guaranteed FiO₂ = 25% (safe margin above 21%)

---

B. Sensitive Oxygen Ratio Monitor Controller (S-ORC) — Dräger Machines

PNEUMATIC PRESSURE-OPERATED SYSTEM:

O₂ pipeline pressure → feeds S-ORC controller valve

S-ORC = a pressure-operated restrictor on the N₂O supply line

↓ O₂ pressure
       │
       ▼
S-ORC valve RESTRICTS N₂O flow proportionally
       │
       ▼
N₂O:O₂ ratio maintained ≤3:1
→ Minimum O₂ ≥ 25% in delivered mixture

• Standard on Dräger Fabius GS, Apollo, Zeus workstations
• Functionally equivalent to Link-25 but uses differential pressure mechanism
• Also pneumatic — no electrical dependency

---

C. Downstream Position of O₂ Flowmeter Tube

FLOWMETER BANK ARRANGEMENT (ASTM MANDATORY):

Left ──────────────────────────── Right
N₂O → Air → (Other gases) → O₂
                              ↑
                    MOST DOWNSTREAM
                    (closest to common gas manifold)

If O₂ flow tube CRACKS or LEAKS:
→ Leaked O₂ enters the COMMON GAS FLOW
→ Delivered mixture becomes MORE oxygenated ✓
→ Patient is NOT at risk of hypoxia

If O₂ were UPSTREAM and cracked:
→ O₂ would leak away from circuit
→ Patient receives hypoxic mixture ✗

This single design principle (O₂ downstream) is one of the most important and frequently examined safety features.

---

D. Minimum O₂ Flow (Basal O₂ Flow)

• Many machines incorporate a fixed minimum O₂ flow of 150–250 mL/min
• This flow cannot be reduced below a set threshold even if O₂ knob is fully turned
• Prevents accidental zero O₂ flow during low-flow anaesthesia

---

E. O₂ Flow Control Knob — Tactile & Visual Identification

O₂ KNOB IS IDENTIFIABLE BY:
├── FLUTED/RIBBED texture (all others smooth)
├── LARGEST diameter of all knobs
├── Projects FURTHEST beyond the control panel
├── Colour: GREEN (internationally, per ISO)
├── Permanently marked "O₂" or "OXYGEN"
└── RECESSED or GUARDED — prevents accidental displacement

→ Identifiable by TOUCH ALONE in darkness/emergency

---

F. O₂ Flush Valve / Button

• Delivers 100% O₂ at 35–75 L/min directly to the common gas outlet
• Completely bypasses flowmeters and vaporisers
• Used for immediate correction of hypoxaemia or circuit wash-out
• Caution: Can cause:
  • Barotrauma if circuit is closed (circuit pressure spikes)
  • Awareness (dilutes volatile agent)
  • PONV (100% O₂ delivered, no agent)

---

6. LOW-PRESSURE SECTION — VAPORISER SAFETY FEATURES

A. Selectatec / Back-Bar Interlock System

Multiple vaporisers on back-bar:

[Sevo] [Iso] [Des]
   ↓
Selectatec mechanical interlock:
→ Turning one vaporiser ON locks all others OFF
→ ONLY ONE agent can be delivered at any time
→ Prevents accidental dual-agent administration

B. Keyed Filling Devices (Agent-Specific Filling)

C. Tipping Lock Mechanism

• If a vaporiser is accidentally tipped, liquid agent can flood the bypass chamber
• The tipping lock prevents use of the vaporiser until it has been held upright and allowed to equilibrate (≥15–30 min)
• Prevents massive volatile agent overdose

D. Temperature Compensation

• Bimetallic strip within vaporiser adjusts gas flow through wick chamber
• Maintains constant output despite ambient temperature fluctuations
• Prevents overdose in warm OT conditions

E. Pressure Compensation

• Modern vaporisers compensate for backpressure from the breathing circuit (pumping effect)
• Especially important with Penlon/Ohmeda TEC series vaporisers

---

7. BREATHING CIRCUIT & VENTILATOR SAFETY FEATURES

A. O₂ Analyser (Paramagnetic/Fuel Cell) — LAST LINE OF DEFENCE

Position: WITHIN breathing circuit (inspiratory limb)
Measures: ACTUAL FiO₂ delivered to patient

If FiO₂ < preset alarm limit (typically 0.18–0.21):
→ ALARM triggers immediately
→ Operator intervenes

This is the FINAL safeguard — catches ANY hypoxic
mixture that has passed through all upstream devices

• Uses paramagnetic principle (O₂ is uniquely paramagnetic)
• Or electrochemical fuel cell (Clark electrode)
• Must be calibrated to 21% (room air) and 100% O₂ before each list
• Most important single device in detecting hypoxic mixture delivery

B. Breathing Circuit Pressure Alarms

C. Adjustable Pressure Limiting (APL) Valve

• Pop-off valve — vents excess gas to scavenging system
• Prevents pressure build-up during spontaneous breathing
• Set to minimum during controlled ventilation, open during spontaneous breathing

D. Unidirectional (One-Way) Valves — Circle System

• Inspiratory and expiratory one-way valves ensure unidirectional gas flow
• Force exhaled gas through CO₂ absorber before re-inhalation
• Failure → CO₂ rebreathing → hypercapnia

E. CO₂ Absorber (Soda Lime / Amsorb / Lithium Hydroxide)

• Absorbs CO₂ by chemical reaction
• Colour indicator changes when exhausted:
  • Soda lime: White → Violet/Purple
  • Amsorb: White → Purple (more reliable)
• Prevents CO₂ rebreathing and hypercapnia
• Exhausted absorber must be changed before use

F. Integrated Spirometry (Volume/Flow Monitoring)

• Measures tidal volume, minute volume, flow-volume loops
• Alarms for low/high tidal volume
• Detects leaks, obstruction, and disconnection

G. Scavenging System

• Removes waste anaesthetic gases from OT environment
• Protects theatre staff from chronic volatile exposure
• Active or passive scavenging — negative pressure controlled to prevent siphoning gas from circuit

---

8. ELECTRICAL & ELECTRONIC SAFETY (MODERN WORKSTATIONS — Q6 June 2017, Q8 Dec 2022)

---

9. PRE-USE SAFETY CHECKLIST

BEFORE EVERY LIST:

1.  Verify O₂ cylinder (pressure) and pipeline (400 kPa)
2.  Verify N₂O, Air cylinders and pipelines
3.  Check all pipeline hoses connected to correct outlets (DISS)
4.  Perform low-pressure leak test (negative pressure test)
5.  Confirm O₂ flowmeter functional — downstream position
6.  Test O₂ failure alarm (disconnect O₂ hose — whistle sounds)
7.  Test O₂ cutoff — N₂O flow drops to zero on O₂ failure
8.  Calibrate O₂ analyser (21% room air → 100%)
9.  Check vaporisers — filled, locked, selectatec functional
10. Test breathing circuit for leaks (positive pressure test)
11. Check CO₂ absorber colour and granule integrity
12. Verify ventilator operation — test lung
13. Confirm all monitoring alarms set and functional
14. Check suction, airway equipment, emergency drugs

---

10. COMPLETE SUMMARY TABLE

---

QUICK REVISION SUMMARY BOX

╔════════════════════════════════════════════════════════════════╗
║       SAFETY FEATURES — DNB VIVA PEARLS                       ║
╠════════════════════════════════════════════════════════════════╣
║ MNEMONIC: "PODS-LOV" for Hypoxic Prevention Devices          ║
║ P — Position of O₂ flowmeter (downstream, rightmost)         ║
║ O — O₂ failure cutoff valve (N₂O shuts off)                  ║
║ D — DISS / PISS (supply safety)                               ║
║ S — S-ORC (Dräger) / Sensitive Oxygen Ratio Controller        ║
║ L — Link-25 (GE/Ohmeda mechanical chain)                      ║
║ O — O₂ flush (emergency 100% O₂ at 35–75 L/min)              ║
║ V — Vigilance: O₂ Analyser (LAST LINE OF DEFENCE)            ║
╠════════════════════════════════════════════════════════════════╣
║ PISS: O₂=2+5 | N₂O=3+5 | Air=1+5 | CO₂=1+6                 ║
║ O₂ knob: FLUTED, largest, projects furthest, GREEN           ║
║ Ritchie Whistle: sounds ≥7 sec on O₂ failure (pneumatic)     ║
║ Link-25 ensures minimum 25% O₂ in N₂O+O₂ mixture only       ║
║ E-cylinder regulator: 40–45 psig < pipeline 50–55 psig       ║
║ (Machine uses pipeline preferentially — preserves cylinder)   ║
║ O₂ analyser: calibrate to 21% + 100% before EVERY list       ║
║ Selectatec: only ONE vaporiser ON at a time                   ║
║ Tipping: do not use vaporiser immediately after tipping       ║
╠════════════════════════════════════════════════════════════════╣
║ COMMON MISTAKES TO AVOID:                                     ║
║ ✗ O₂ flowmeter placed upstream — must be DOWNSTREAM          ║
║ ✗ Link-25 protects against 3rd gas — IT DOES NOT             ║
║ ✗ Forgetting O₂ analyser calibration before list             ║
║ ✗ Not closing E-cylinder during pipeline operation           ║
║ ✗ Confusing PISS (cylinders) with DISS (pipelines)           ║
╚════════════════════════════════════════════════════════════════╝

---

---

SAFETY FEATURES IN MODERN DAY ANAESTHESIA MACHINE

DNB Final Anaesthesia — Complete 10-Mark Distinction Answer

Questions 1–8 (June 2009 → Dec 2022)

---

QUESTION SUMMARY

All questions share the same core content. Q7 specifically focuses on O₂ supply failure systems. The complete answer below covers all 8 questions comprehensively.

---

1. INTRODUCTION

• ASTM F1850-00 (USA — Anaesthesia workstation)
• ISO 80601-2-13:2011 (International standard)
• BIS 7885 / BIS 8662 (India — Bureau of Indian Standards)
• AAGBI 2012 machine check guidelines (UK)
• FDA Pre-use Checklist 2008 (USA)

---

2. GAS DELIVERY PATHWAY — OVERVIEW

┌──────────────────────────────────────────────────────────┐
│           HOSPITAL PIPELINE SUPPLY                        │
│           (400 kPa / 50–55 psig)                          │
│           O₂  |  N₂O  |  Air  |  CO₂                     │
└──────────────────────┬───────────────────────────────────┘
                       │  DISS connectors
                       ▼
┌─────────────────────────────────────────────────────────┐
│         HIGH-PRESSURE SECTION                            │
│  E-Cylinders (backup) via PISS + Hanger Yoke            │
│  High-pressure regulators (E-cyl → 40–45 psig)          │
│  Check valves | Pressure gauges                          │
└──────────────────────┬──────────────────────────────────┘
                       │
                       ▼
┌─────────────────────────────────────────────────────────┐
│       INTERMEDIATE-PRESSURE SECTION                      │
│  O₂ Failure Warning Device (Ritchie Whistle)            │
│  O₂ Failure Cutoff (N₂O shuts off)                      │
│  Second-stage regulators                                 │
│  Flowmeters (Thorpe tubes / Electronic)                  │
│  Link-25 / S-ORC Proportioning System                   │
│  O₂ flowmeter DOWNSTREAM (rightmost)                    │
│  O₂ flush valve                                         │
└──────────────────────┬──────────────────────────────────┘
                       │
                       ▼
┌─────────────────────────────────────────────────────────┐
│            LOW-PRESSURE SECTION                          │
│  Vaporiser back-bar (Selectatec interlock)              │
│  Keyed filling devices (agent-specific)                 │
│  Tipping lock | Temperature compensation                │
│  Common gas outlet                                      │
└──────────────────────┬──────────────────────────────────┘
                       │
                       ▼
┌─────────────────────────────────────────────────────────┐
│         BREATHING CIRCUIT & VENTILATOR                   │
│  O₂ Analyser (LAST LINE OF DEFENCE)                     │
│  Pressure alarms | APL valve                            │
│  Unidirectional valves | CO₂ absorber                  │
│  Integrated spirometry | Scavenging system              │
└──────────────────────┬──────────────────────────────────┘
                       │
                       ▼
                    PATIENT

---

3. HIGH-PRESSURE SECTION SAFETY FEATURES

A. PIN INDEX SAFETY SYSTEM (PISS) — Cylinder Supply

HANGER YOKE has 2 METAL PINS projecting outward
Cylinder valve has matching HOLES — only correct gas fits

Gas              Pin Positions
─────────────────────────────
Oxygen      →    Pins 2 and 5
Nitrous Oxide →  Pins 3 and 5
Air         →    Pins 1 and 5
CO₂         →    Pins 1 and 6
He/O₂ mix   →    Pins 2 and 4
Cyclopropane →   Pins 3 and 6

Each combination is UNIQUE
→ Wrong cylinder physically CANNOT be mounted

• Bodok seal (non-interchangeable neoprene washer) between cylinder valve and yoke → gas-tight seal
• Particulate filter → traps debris from cylinder gas before entering machine
• Unidirectional check valve in double-yoke assemblies:
  • Prevents gas transfer from full to empty cylinder
  • Prevents gas escaping from open yoke when no cylinder is mounted
  • Ensures machine draws from pipeline preferentially during normal operation

Critical Design Principle (Miller's 10e / Barash 9e): The E-cylinder high-pressure regulator output is set at 40–45 psig, which is deliberately lower than pipeline supply pressure (50–55 psig). This means the machine always preferentially draws from the pipeline, automatically preserving cylinder contents for emergency use. If pipeline pressure drops below 40–45 psig, the E-cylinder seamlessly takes over — without any intervention by the anaesthetist.

• Fails if pins are deliberately removed or mutilated
• Fails if more than one Bodok seal (washer) is placed
• All gas mixtures containing >7% CO₂ share the same pin arrangement as pure CO₂ — source of reported incidents
• Does NOT protect against mislabelled cylinders

---

B. DIAMETER INDEX SAFETY SYSTEM (DISS) — Pipeline Supply

Each pipeline gas has a UNIQUE threaded connector:
- Specific THREAD diameter (different for each gas)
- Specific NIPPLE size (non-interchangeable)

O₂ pipeline hose connector ≠ N₂O pipeline inlet
→ Cannot physically cross-connect pipeline hoses

• Used at wall outlet connections and machine pipeline inlets
• Gas-specific: O₂, N₂O, Air, CO₂, He all have unique DISS connectors
• Supplemented by colour coding for visual identification

---

C. COLOUR CODING OF GAS CYLINDERS AND PIPELINES

Important: The USA has no FDA standard for cylinder colour. Reading the label and checking the PISS is always mandatory — never rely on colour alone.

---

D. PRESSURE GAUGES

• Each gas (O₂, N₂O, Air) has a dedicated, independent pressure gauge visible on the front panel
• Normal pipeline pressure reading = 400 kPa (approximately 50–55 psig)
• Normal full O₂ E-cylinder = 13,700 kPa (approximately 2000 psig)
• Normal full N₂O E-cylinder = 5170 kPa (approximately 750 psig)
• Allows immediate visual verification of supply status before and during use

---

4. OXYGEN SUPPLY FAILURE PREVENTION SYSTEMS (Q7 — Dec 2021)

A. Oxygen Failure Warning Device (OFWD) — "Ritchie Whistle"

Normal O₂ pipeline pressure = 400 kPa (50–55 psig)
                │
                │  Pipeline fails or O₂ supply exhausted
                ▼
O₂ pressure FALLS below threshold
(typically < 200 kPa / ~30 psig)
                │
                ▼
┌──────────────────────────────────────┐
│   RITCHIE WHISTLE ACTIVATES          │
│   Audible alarm — minimum 7 seconds  │
│   (ASTM F1850 mandatory requirement) │
│   Powered by STORED O₂ pressure      │
│   → Works WITHOUT electricity        │
└──────────────────────────────────────┘
                │
                │  If pressure continues to drop
                ▼
        O₂ FAILURE CUTOFF ACTIVATES
        (see below)

• Power failures can coincide with gas supply emergencies
• Pneumatic alarm is fail-safe — operates on the very gas pressure it monitors
• Electrical alarm would fail precisely when most needed

---

B. O₂ Failure Cutoff Valve (N₂O Automatic Shut-off / Hypoxic Guard Interlock)

O₂ pressure drops below threshold
              │
              ▼
Pneumatic signal to N₂O supply valve is LOST
              │
              ▼
N₂O valve is SPRING-LOADED CLOSED
(fail-safe = closed when no signal)
              │
              ▼
N₂O flow → ZERO automatically
              │
              ▼
On some machines: ambient air admitted to circuit
(prevents complete apnoea — patient breathes air)

• Present on ALL modern anaesthesia machines — mandatory per ASTM
• Works in conjunction with proportioning systems
• Sequentially: O₂ fails → whistle sounds → N₂O cuts off → O₂ analyser alarms

---

C. Second-Stage Pressure Regulators

• Reduce variable intermediate pressure to a constant low pressure before flowmeters
• Ensures stable, consistent gas flow rates regardless of fluctuating pipeline pressure
• Separate regulator for each gas (O₂, N₂O, Air)
• O₂ regulator set at slightly higher output than N₂O → preferential O₂ flow maintained during pressure fluctuations

---

5. HYPOXIA PREVENTION SAFETY DEVICES (Q2, Q3, Q4 — HIGHEST EXAM YIELD)

A. Link-25 Proportion-Limiting Control System — GE/Datex-Ohmeda Machines

N₂O flow control valve
Sprocket: 29 TEETH
     │
     │←──── MECHANICAL CHAIN LINK ────→│
     │                                  │
     └──── O₂ flow control valve ───────┘
           Sprocket: 14 TEETH

GEAR RATIO: 29 ÷ 14 ≈ 2.07 : 1

SCENARIO 1 — Operator increases N₂O:
→ N₂O sprocket (29T) turns
→ Chain FORCES O₂ sprocket (14T) to rotate
→ O₂ flow AUTOMATICALLY INCREASES
→ N₂O:O₂ ratio CANNOT exceed 3:1
→ Minimum O₂ = 25% at all times ✓

SCENARIO 2 — Operator decreases O₂:
→ O₂ sprocket turns
→ Chain FORCES N₂O sprocket to turn
→ N₂O flow AUTOMATICALLY DECREASES
→ Ratio maintained ≤ 3:1 ✓

• Entirely mechanical — no electrical power required
• Minimum guaranteed O₂ concentration = 25% (safe margin above 21%)
• Maximum N₂O:O₂ ratio allowed = 3:1
• Used in: GE Aespire, Avance, Aisys Carestation (traditional models)
• On modern GE Aisys electronic models: electronic flow control replaces chain with software algorithm

• Protects only in N₂O + O₂ binary mixture — does NOT account for third gas (Air, He)
• Does NOT protect against pipeline crossover (N₂O in O₂ pipeline)
• Does NOT protect if gas cylinders are mislabelled
• Does NOT guarantee FiO₂ > 25% if O₂ flowmeter tube is cracked upstream

---

B. Sensitive Oxygen Ratio Monitor Controller (S-ORC) — Dräger Machines

O₂ pipeline pressure feeds into S-ORC controller

S-ORC = pneumatically operated restrictor valve
        on the N₂O supply line

Normal O₂ pressure → S-ORC fully OPEN
    → N₂O flows freely (but still ratio-controlled)

↓ O₂ pressure → S-ORC valve partially CLOSES
    → N₂O flow RESTRICTED proportionally
    → N₂O:O₂ ratio maintained ≤ 3:1
    → Minimum O₂ ≥ 25%

O₂ pressure = 0 → S-ORC fully CLOSED
    → N₂O flow = ZERO

• Used on: Dräger Fabius GS, Apollo, Zeus, Perseus
• Analogous function to Link-25 but uses differential pressure rather than mechanical sprockets
• Also entirely pneumatic — no electrical dependency
• Minimum O₂ guaranteed = 25% (same as Link-25)

---

C. Downstream Position of O₂ Flowmeter — ASTM Mandatory Design

FLOWMETER BANK — CORRECT ARRANGEMENT (ASTM MANDATORY):

LEFT ←──────────────────────────────→ RIGHT
  N₂O  |  Air  |  Other gases  |  O₂
                                  ↑
                         MOST DOWNSTREAM
                         (closest to common manifold outlet)

If O₂ tube CRACKS:
    Leaked O₂ → enters common gas flow → FiO₂ ↑ (safe) ✓

If O₂ were UPSTREAM and cracked:
    Leaked O₂ → escapes before mixing → patient gets hypoxic mix ✗

Examiner's favourite: "What is the significance of the position of O₂ flowmeter in the bank?" — Answer: O₂ is always placed most downstream (rightmost) so that any O₂ flowmeter tube leak enriches rather than depletes the delivered gas mixture. This is mandated by ASTM F1850.

---

D. Minimum O₂ Flow (Basal O₂ Flow)

• Many modern machines incorporate a fixed minimum O₂ flow of 150–250 mL/min that cannot be reduced below a set threshold
• Controlled by a mechanical stop on the O₂ flow control valve
• Prevents accidental or deliberate setting of zero O₂ flow
• Ensures a baseline oxygenating flow is always present even at minimal total fresh gas flows

---

E. O₂ Flow Control Knob — Tactile, Visual and Physical Identification

O₂ FLOW CONTROL KNOB IS IDENTIFIABLE BY ALL SENSES:

TOUCH (tactile):
├── FLUTED / RIBBED surface texture
│   (all other gas knobs are SMOOTH)
├── LARGEST diameter of all flow control knobs
└── Projects FURTHEST beyond the control panel face

SIGHT (visual):
├── Colour: GREEN (internationally per ISO)
├── Permanently labelled "O₂" or "OXYGEN"
└── Chemical symbol engraved

POSITION:
└── Always at RIGHTMOST end of flowmeter bank

PROTECTION:
└── Recessed into panel or surrounded by guard/barrier
    → Prevents accidental displacement of preset position

---

F. O₂ Flush Valve / Oxygen Flush Button

• Delivers 100% O₂ at 35–75 L/min directly to the common gas outlet
• Completely bypasses all flowmeters, proportioning systems, and vaporisers
• Instantaneous correction tool for severe hypoxia or circuit contamination

Rule: Always open APL valve or switch to manual mode before using O₂ flush in a closed-circuit system.

---

6. FLOWMETER SAFETY FEATURES

Thorpe Tube / Rotameter Safety Design

• Variable orifice flowmeter — tapered glass tube with a bobbin/float
• Float rises proportionally to gas flow — read at top of float (flat-topped) or midpoint (ball float)
• Each Thorpe tube is gas-specific — cannot be interchanged (different tube taper, different float density)
• Tubes are colour-coded and permanently labelled

• Dirt or static electricity → float sticks → misrepresents actual flow
• Damaged tube or float → erroneous reading
• Must be kept vertical for accurate measurement (gravity-dependent device)
• Modern machines increasingly replace with electronic mass flow sensors (hot-wire anemometry, differential pressure transducers) — more accurate, less prone to sticking

---

7. LOW-PRESSURE SECTION — VAPORISER SAFETY FEATURES

A. Selectatec Back-Bar Interlock System

BACK-BAR with 3 vaporiser slots:
[Sevoflurane] [Isoflurane] [Desflurane]

SELECTATEC INTERLOCK MECHANISM:
→ Turning any ONE vaporiser ON
→ Mechanically LOCKS all other vaporiser knobs in OFF position
→ ONLY ONE volatile agent can be selected at any time

Protection: Prevents simultaneous delivery of two volatile agents
            (e.g., both sevoflurane AND isoflurane delivered = overdose)

---

B. Agent-Specific Keyed Filling Devices (Colour-Coded)

• Physically impossible to fill wrong agent into a vaporiser using keyed system
• Prevents agent mislabelling at source

---

C. Tipping Lock Mechanism

NORMAL:
Vaporiser upright → liquid agent in wick chamber
→ Gas flows over wick → vaporises at correct concentration

TIPPING:
Vaporiser tilted/inverted → liquid agent floods BYPASS chamber
→ If used immediately:
   All gas passes through liquid → MASSIVE OVERDOSE

TIPPING LOCK:
→ Mechanical interlock PREVENTS vaporiser from being turned ON
   immediately after tipping
→ Must remain upright ≥15–30 min before use
   (liquid drains back to correct chamber)

---

D. Temperature Compensation (Bimetallic Strip)

• As temperature rises → anaesthetic vapour pressure increases → higher concentration delivered without compensation
• Bimetallic strip within vaporiser warps with temperature change → adjusts gas bypass ratio automatically
• Maintains constant vaporiser output across a range of ambient temperatures (typically 15–35°C)
• Without this: warm OT → vaporiser overdoses patient

---

E. Pressure Compensation (Anti-Pumping Effect)

• During IPPV: positive pressure from circuit can drive gas backwards into vaporiser (pumping effect)
• Modern vaporisers have pressure-compensating mechanisms (wicks, baffles, long inlet tubing)
• Prevents fluctuating agent output during mechanical ventilation

---

8. BREATHING CIRCUIT SAFETY FEATURES

A. Oxygen Analyser — THE LAST LINE OF DEFENCE

LOCATION: Inspiratory limb of breathing circuit
          (downstream of vaporiser and common gas outlet)

MEASURES: Actual FiO₂ being DELIVERED to patient

TECHNOLOGY:
├── Paramagnetic analyser (O₂ is uniquely paramagnetic)
└── Electrochemical fuel cell (Clark electrode)

ALARM THRESHOLD: FiO₂ < 0.18–0.21 (operator-set)

If ANY upstream failure allows hypoxic mixture:
→ O₂ analyser DETECTS it
→ ALARM triggers IMMEDIATELY
→ Anaesthetist intervenes

This device catches failures that ALL other devices missed

1. Calibrate to 21% → expose probe to room air → confirm reading 0.21
2. Calibrate to 100% → flush with 100% O₂ → confirm reading 1.0
3. Set alarm threshold appropriately

Examiner pearl: The O₂ analyser is described as the "last line of defence" because it is the only device that measures what the patient actually receives, not what was intended to be delivered. All other devices prevent errors upstream; the O₂ analyser detects any error that slipped through.

---

B. Airway Pressure Alarms

---

C. Adjustable Pressure Limiting (APL) Valve

• Pressure-relief (pop-off) valve — vents excess gas to scavenging when circuit pressure exceeds set value
• Spontaneous ventilation: APL fully open (patient breathes against minimal resistance)
• Controlled ventilation: APL closed (or set to appropriate pressure for IPPV)
• Prevents barotrauma from gas accumulation in circuit
• Failure to open APL before switching to manual mode → pressure buildup → barotrauma

---

D. Unidirectional (One-Way) Valves — Circle System

INSPIRATORY UNIDIRECTIONAL VALVE:
→ Gas flows ONLY: Fresh gas → patient (forward)
→ Prevents exhaled gas from re-entering inspiratory limb

EXPIRATORY UNIDIRECTIONAL VALVE:
→ Gas flows ONLY: Patient → CO₂ absorber → reservoir bag (forward)
→ Prevents fresh gas from contaminating expiratory limb

Effect: Forces ALL exhaled gas through CO₂ absorber
→ CO₂ removed before re-inhalation
→ Ensures unidirectional circular flow

• Valve leaflets must open freely and seat completely
• Stuck open: CO₂ rebreathing
• Stuck closed: circuit obstruction → high airway pressure alarm

---

E. CO₂ Absorber (Soda Lime / Amsorb Plus / Lithium Hydroxide)

• Ca(OH)₂ = 94%, NaOH = 5%, KOH = 1%, + silica (hardener) + colour indicator

CO₂ + H₂O → H₂CO₃ (carbonic acid)
H₂CO₃ + 2NaOH → Na₂CO₃ + 2H₂O
Na₂CO₃ + Ca(OH)₂ → CaCO₃ + 2NaOH (NaOH recycled)

Net: CO₂ + Ca(OH)₂ → CaCO₃ + H₂O + HEAT

Viva pearl: Exhausted soda lime may partially recover colour overnight (NaOH redistribution) — but remains functionally exhausted. Always change if discoloured before use.

---

F. Integrated Spirometry / Volume Monitoring

• Measures tidal volume (TV), minute volume (MV), flow-volume loops continuously
• Alarms for low TV (disconnection, leak) and high TV (excessive ventilation)
• Flow-volume loops identify: obstruction, air trapping, circuit leaks, bronchospasm in real time

---

G. Waste Anaesthetic Gas Scavenging System (WAGSS)

• Collects waste gases from APL valve and ventilator relief valve
• Channels to outside atmosphere or hospital exhaust system
• Active (vacuum-driven) or passive (flow-driven) systems
• Protects OT staff from chronic volatile agent and N₂O exposure
• Safety feature: Negative pressure relief valve prevents siphoning gas from circuit if vacuum too high

---

9. ELECTRICAL AND ELECTRONIC SAFETY FEATURES (Q6 — June 2017, Q8 — Dec 2022)

---

10. PRE-USE MACHINE SAFETY CHECKLIST

BEFORE EVERY ANAESTHETIC LIST:

GAS SUPPLY:
□ 1. O₂ cylinder present, turned on, pressure adequate (≥ half full)
□ 2. N₂O, Air cylinders present and checked
□ 3. Pipeline hoses connected correctly (check colour + DISS)
□ 4. All pipeline pressure gauges reading 400 kPa

O₂ FAILURE TEST:
□ 5. Disconnect O₂ pipeline → Ritchie whistle sounds
□ 6. N₂O flow drops to zero on O₂ failure (cutoff test)
□ 7. Reconnect O₂ pipeline

FLOWMETER & CONTROLS:
□ 8. O₂ flowmeter functional — confirmed downstream position
□ 9. All flow controls move smoothly — O₂ knob identified

LEAK TEST (Low-pressure section):
□ 10. Perform negative pressure test (Ohmeda) or
       positive pressure circuit test (Dräger)
□ 11. No significant leak detected

VAPORISER:
□ 12. Filled with correct agent (confirm via keyed filler)
□ 13. Selectatec interlock functional
□ 14. Not recently tipped

MONITORING:
□ 15. O₂ analyser calibrated (21% and 100%)
□ 16. O₂ analyser alarm set at appropriate threshold
□ 17. All other monitoring alarms functional and set
□ 18. ETCO₂ circuit connected and zeroed

BREATHING CIRCUIT:
□ 19. Circuit assembled correctly — no leaks
□ 20. CO₂ absorber — colour confirmed fresh
□ 21. Unidirectional valves moving freely

VENTILATOR:
□ 22. Ventilator operational — test lung inflation confirmed

EMERGENCY EQUIPMENT:
□ 23. Suction functional
□ 24. Airway equipment checked (laryngoscope, ETT, LMA, bougie)
□ 25. Emergency drugs drawn up and labelled

---

11. COMPLETE CLASSIFICATION SUMMARY TABLE

╔═══════════════════════════════════════════════════════════════════════╗
║              ALL SAFETY FEATURES — CLASSIFIED BY STAGE               ║
╠═══════════════╦═══════════════════════════╦══════════════════════════╣
║ STAGE         ║ SAFETY DEVICE             ║ PREVENTS                 ║
╠═══════════════╬═══════════════════════════╬══════════════════════════╣
║ HIGH-PRESSURE ║ PISS (cylinders)          ║ Wrong cylinder           ║
║               ║ DISS (pipelines)          ║ Wrong pipeline           ║
║               ║ Colour coding             ║ Gas misidentification    ║
║               ║ Pressure gauges           ║ Silent supply failure    ║
║               ║ Check valves              ║ Backflow / cross-fill    ║
║               ║ High-pressure regulator   ║ Pressure surge           ║
╠═══════════════╬═══════════════════════════╬══════════════════════════╣
║ O₂ FAILURE    ║ Ritchie Whistle (OFWD)    ║ Silent O₂ failure        ║
║ SYSTEMS       ║ O₂ Failure Cutoff Valve   ║ Pure N₂O delivery        ║
║               ║ Second-stage regulators   ║ Pressure fluctuation     ║
╠═══════════════╬═══════════════════════════╬══════════════════════════╣
║ HYPOXIC       ║ Link-25 (GE)              ║ N₂O:O₂ ratio >3:1        ║
║ MIXTURE       ║ S-ORC (Dräger)            ║ N₂O:O₂ ratio >3:1        ║
║ PREVENTION    ║ O₂ flowmeter downstream   ║ Tube leak → hypoxia      ║
║               ║ Minimum O₂ flow           ║ Zero O₂ flow             ║
║               ║ Fluted O₂ knob            ║ Gas misidentification    ║
║               ║ Recessed knobs            ║ Accidental displacement  ║
║               ║ O₂ flush valve            ║ Acute hypoxia            ║
╠═══════════════╬═══════════════════════════╬══════════════════════════╣
║ VAPORISER     ║ Selectatec interlock      ║ Two agents simultaneously║
║               ║ Keyed filling devices     ║ Wrong agent fill         ║
║               ║ Tipping lock              ║ Liquid agent overdose    ║
║               ║ Temperature compensation  ║ Warm OT overdose         ║
║               ║ Pressure compensation     ║ IPPV pumping effect      ║
╠═══════════════╬═══════════════════════════╬══════════════════════════╣
║ BREATHING     ║ O₂ ANALYSER ← LAST LINE  ║ ALL hypoxic mix failures ║
║ CIRCUIT       ║ Disconnect / Low-P alarm  ║ Circuit separation       ║
║               ║ High-P alarm              ║ Barotrauma               ║
║               ║ Apnoea alarm              ║ Undetected apnoea        ║
║               ║ APL valve                 ║ Pressure build-up        ║
║               ║ Unidirectional valves     ║ CO₂ rebreathing          ║
║               ║ CO₂ absorber + indicator  ║ Hypercapnia              ║
║               ║ Integrated spirometry     ║ Volume/leak errors       ║
║               ║ Scavenging (WAGSS)        ║ OT staff exposure        ║
╠═══════════════╬═══════════════════════════╬══════════════════════════╣
║ ELECTRICAL    ║ Battery backup (UPS)      ║ Power failure            ║
║               ║ Pre-use self-check        ║ Equipment fault          ║
║               ║ Electronic gas control    ║ Human ratio error        ║
║               ║ Tiered alarm system       ║ Alarm fatigue            ║
║               ║ Multigas analyser         ║ Wrong volatile agent     ║
╚═══════════════╩═══════════════════════════╩══════════════════════════╝

---

12. QUICK REVISION SUMMARY BOX

╔══════════════════════════════════════════════════════════════════════╗
║         SAFETY FEATURES — DNB DISTINCTION VIVA PEARLS              ║
╠══════════════════════════════════════════════════════════════════════╣
║  MNEMONIC — Hypoxic Prevention: "PODS-LOV"                         ║
║  P — Position of O₂ flowmeter (downstream/rightmost, ASTM)         ║
║  O — O₂ failure cutoff valve (N₂O auto shut-off)                   ║
║  D — DISS (pipelines) / PISS (cylinders) — supply safety           ║
║  S — S-ORC (Dräger) — pneumatic proportioning                      ║
║  L — Link-25 (GE) — mechanical chain proportioning                 ║
║  O — O₂ flush (100% O₂ at 35–75 L/min — emergency correction)     ║
║  V — Vigilance: O₂ Analyser = LAST LINE OF DEFENCE                ║
╠══════════════════════════════════════════════════════════════════════╣
║  KEY NUMBERS:                                                        ║
║  • PISS pins: O₂=2+5 | N₂O=3+5 | Air=1+5 | CO₂=1+6               ║
║  • Normal pipeline pressure = 400 kPa (50–55 psig)                 ║
║  • E-cylinder regulator output = 40–45 psig (< pipeline)           ║
║  • Ritchie Whistle: sounds ≥7 seconds (ASTM mandatory)             ║
║  • Link-25/S-ORC: minimum O₂ = 25%, max N₂O:O₂ = 3:1             ║
║  • O₂ flush: 35–75 L/min, 100% O₂, bypasses vaporiser             ║
║  • Soda lime capacity: 1 kg absorbs ~120 L CO₂                     ║
╠══════════════════════════════════════════════════════════════════════╣
║  EXAM DIFFERENTIATORS:                                               ║
║  • Link-25 = GE/Ohmeda (mechanical) | S-ORC = Dräger (pneumatic)  ║
║  • Both: min O₂ 25%, but NEITHER protects against 3rd gas or       ║
║    pipeline crossover — O₂ analyser catches these                   ║
║  • O₂ knob: FLUTED + LARGEST + PROJECTS FURTHEST + GREEN          ║
║  • Tipping lock: prevents use — NOT just a mechanical stop          ║
║  • Selectatec: ONE vaporiser ON = all others mechanically LOCKED   ║
╠══════════════════════════════════════════════════════════════════════╣
║  COMMON EXAM MISTAKES TO AVOID:                                      ║
║  ✗ Saying O₂ flowmeter is upstream — it MUST be downstream         ║
║  ✗ Link-25 protects against 3rd gas dilution — it does NOT         ║
║  ✗ Ritchie Whistle is electrical — it is PNEUMATIC (fail-safe)     ║
║  ✗ Forgetting to calibrate O₂ analyser before list                 ║
║  ✗ Using vaporiser immediately after tipping                        ║
║  ✗ Giving O₂ flush in closed circuit without opening APL           ║
╚══════════════════════════════════════════════════════════════════════╝

---

---

GENERAL — ANAESTHESIA EQUIPMENT

DNB Final Anaesthesia | Distinction-Level Answers (Questions 1–7)

---

Q1 — EVOLUTION OF THE ROTAMETER

Introduction

---

Principle of Operation

VARIABLE ORIFICE FLOWMETER (Thorpe Tube)

Tapered, transparent borosilicate glass tube
(wider at top, narrower at bottom)
            │
            │  Gas enters from BOTTOM
            │  (controlled by needle valve)
            ▼
    ┌───────────────┐  ← Top (wider)
    │     ↑         │
    │   BOBBIN/     │  ← Float rises to equilibrium
    │   FLOAT       │     where UPWARD force = DOWNWARD force
    │     ↑         │
    └───────────────┘  ← Bottom (narrower)
            │
     Gas flow in

At equilibrium:
Upward force (gas flow) = Downward force (float weight)
→ Float height indicates FLOW RATE on calibrated scale

• Viscosity dominant at LOW flows (lower, narrow portion — tubular orifice)
• Density dominant at HIGH flows (upper, wide portion — orificial flow)
• Each tube is therefore gas-specific — calibrated for the physical properties of one gas

---

Historical Evolution of the Rotameter

---

Types of Flowmeter Floats (Bobbins)

---

Sources of Flowmeter Error (Applied)

ERROR SOURCES:
├── Dirt/debris → float sticks → false reading
├── Static electricity → float clings to wall → false reading
├── Damaged tube (cracked, chipped) → calibration lost
├── Wrong float in wrong tube (non-specific float)
├── Tilted tube → gravity component altered → inaccurate
├── Back pressure (IPPV pumping effect) → variable output
└── Reading at wrong point on float (top vs. centre)

• Flowmeter errors can deliver hypoxic mixtures undetected without O₂ analyser
• ASTM mandates O₂ flowmeter in downstream position as safety backup
• Modern electronic sensors eliminate mechanical sticking as an error source

---

Modern Electronic Flow Measurement

ELECTRONIC MASS FLOW SENSOR (hot-wire anemometry):
→ Gas flows past a heated chamber of known volume
→ Energy required to maintain chamber temperature
  is proportional to specific heat × flow rate
→ Flow extrapolated from energy input
→ Each gas requires its own sensor (gas-specific)
→ Display: digital readout (no mechanical tube)
→ Advantage: No sticking, no tilt error, no static
→ Disadvantage: Requires electrical power;
  backup mechanical O₂ tube usually present

---

Quick Summary — Rotameter

╔══════════════════════════════════════════════════════════╗
║ • Invented: Kuppers 1908; anaesthesia use: 1937          ║
║ • Variable orifice principle (Thorpe tube)               ║
║ • Low flow: viscosity dominant; High flow: density       ║
║ • Read: TOP of bobbin / CENTRE of ball float             ║
║ • O₂ tube MUST be downstream (rightmost) — ASTM          ║
║ • Float spins = gas is flowing (confirms patency)        ║
║ • Modern: replaced by electronic mass flow sensors       ║
╚══════════════════════════════════════════════════════════╝

---

---

Q2 — LOW FLOW ANAESTHESIA (LFA): DEFINITION, ADVANTAGES, DISADVANTAGES

Introduction

---

Classification of Anaesthesia by Fresh Gas Flow

Classic definition (Baum 1998): LFA = FGF ≤ 1 L/min in a circle system with CO₂ absorber.

---

Prerequisites for Safe LFA

MANDATORY REQUIREMENTS:
├── Circle breathing system (rebreathing circuit)
├── Functional CO₂ absorber (soda lime/Amsorb — fresh)
├── Leak-free circuit (machine + connections)
├── Calibrated agent-specific vaporiser
├── Continuous O₂ analyser monitoring (mandatory)
├── Continuous volatile agent analyser (ideal)
├── Capnography (ETCO₂ monitoring)
└── Adequate pre-oxygenation/denitrogenation before switching to LFA

---

Conducting LFA — Practical Steps

PHASE 1: INDUCTION & WASHOUT (High flow)
FGF = 4–6 L/min for first 10–15 minutes
→ Denitrogenation of circuit (N₂ washed out)
→ Equilibration of agent in circuit
→ Ensures N₂ does not accumulate in rebreathing circuit

PHASE 2: TRANSITION TO LOW FLOW
Reduce FGF to 0.5–1 L/min
→ Set O₂ flow: 250–500 mL/min (covers metabolic O₂ uptake 200–250 mL/min)
→ Set N₂O (if used): 250–500 mL/min
→ ↑ Vaporiser setting (agent consumed faster at low FGF)

PHASE 3: MAINTENANCE
FGF 0.5–1 L/min; monitor:
→ O₂ analyser: FiO₂ ≥ 0.3 (never <0.25)
→ ETCO₂: 35–40 mmHg (CO₂ absorber working)
→ Agent concentration in circuit (inspired agent)
→ Reservoir bag filling (no leak)

PHASE 4: WASHOUT (end of case)
Return to high FGF for 5–10 min before extubation
→ Washes out volatile agent
→ Restores circuit to atmospheric composition

---

Advantages of LFA

A. Economic

B. Environmental

• ↓ Greenhouse gas emissions — volatile agents (desflurane especially) have global warming potential (GWP)
• Desflurane GWP = 2540× CO₂; N₂O GWP = 265× CO₂
• LFA reduces OT atmospheric pollution
• RCOA/AAGBI 2022 Green Anaesthesia guidance strongly recommends LFA as environmentally responsible practice

C. Physiological (Patient Benefits)

D. Monitoring Advantage

• Forces anaesthetist to monitor circuit gas composition closely
• Promotes engaged, active monitoring practice

---

Disadvantages of LFA

---

Contraindications to LFA

• Malignant hyperthermia (need high FGF to rapidly wash out agent)
• Suspected CO poisoning (need 100% O₂ at high flow)
• Circuit leak cannot be corrected
• Exhausted CO₂ absorber not replaceable
• Unknown/unpredictable O₂ consumption (sepsis, high metabolic states)

---

Quick Summary — Low Flow Anaesthesia

╔══════════════════════════════════════════════════════════════╗
║ LFA = FGF ≤1 L/min in circle system with CO₂ absorber       ║
║ Washout first: 4–6 L/min × 15 min → then reduce to LFA      ║
║ Min O₂ flow: 250–500 mL/min (covers 200–250 mL/min uptake)  ║
║ MANDATORY: O₂ analyser + capnograph + fresh CO₂ absorber    ║
║ Benefits: ↓cost, ↓pollution, warmth, humidity               ║
║ Risks: N₂ accumulation, hypoxia, Compound A (sevo+KOH lime) ║
║ Compound A: use Amsorb or FGF >1 L/min with sevoflurane     ║
║ CO formation: dried soda lime + desflurane — "Monday risk"  ║
╚══════════════════════════════════════════════════════════════╝

---

---

Q3 — PRESSURE REDUCING VALVE (PRESSURE REGULATOR) — FUNCTIONAL ANALYSIS

Introduction

• Pipeline supply: 400 kPa (50–55 psig) — relatively stable
• Full E-cylinder O₂: ~13,700 kPa (~2000 psig) — very high, variable as cylinder empties
• Machine flowmeters operate safely at: ~100–200 kPa (~15–30 psig)

---

Why is Pressure Reduction Necessary?

PROBLEM:
Full O₂ E-cylinder = 13,700 kPa
As cylinder empties → pressure FALLS continuously
→ If directly connected to flowmeters:
   → Gas flow rate changes as pressure changes
   → Accurate flow measurement IMPOSSIBLE
   → Risk of high-pressure damage to equipment

SOLUTION: Pressure Regulator
→ Reduces high/variable input pressure
→ Delivers CONSTANT, LOW output pressure
→ Flow rate now independent of cylinder fullness
→ Accurate flowmeter function maintained

---

Types of Pressure Regulators

1. Single-Stage Regulator

• Reduces pressure in one step
• Output pressure slightly variable with input changes
• Used for: simple applications

2. Two-Stage (Double) Regulator

• Reduces pressure in two sequential steps
• Stage 1: High → Intermediate (e.g., 13,700 → 1000 kPa)
• Stage 2: Intermediate → Low working pressure (e.g., 1000 → 100 kPa)
• Output pressure more constant and precise
• Used in: modern anaesthesia machines (standard)

---

Functional Anatomy of a Pressure Reducing Valve

HIGH PRESSURE GAS IN (cylinder side)
              │
              ▼
┌─────────────────────────────────────────┐
│         PRESSURE REDUCING VALVE          │
│                                         │
│  ┌─────────────────────────────────┐    │
│  │  INLET VALVE                    │    │
│  │  (poppet valve / ball valve)    │    │
│  │  Opens to let high-P gas in     │    │
│  └──────────────┬──────────────────┘    │
│                 │                        │
│         CHAMBER (low pressure side)     │
│                 │                        │
│  ┌──────────────┴───────────────────┐   │
│  │  DIAPHRAGM (flexible)            │   │
│  │  Senses output pressure          │   │
│  │  Connected to inlet valve via    │   │
│  │  lever/spring                    │   │
│  └──────────────────────────────────┘   │
│                 │                        │
│  ADJUSTING SPRING (sets output P)       │
│  (factory-set; not operator-adjustable) │
│                 │                        │
│  SAFETY RELIEF VALVE                   │
│  (opens if output P exceeds safe limit) │
└─────────────────────────────────────────┘
              │
              ▼
LOW PRESSURE GAS OUT (to flowmeters)
~100–200 kPa / 15–30 psig

---

Mechanism of Action — Step by Step

STEP 1:
High-pressure gas enters chamber through poppet valve
→ Chamber pressure rises

STEP 2:
Rising chamber pressure acts on DIAPHRAGM
→ Diaphragm deflects upward (against spring)

STEP 3:
Diaphragm movement CLOSES poppet valve
(via lever mechanism)
→ No more high-pressure gas enters

STEP 4:
Gas is used (flows downstream to flowmeter)
→ Chamber pressure FALLS

STEP 5:
Falling pressure → spring pushes diaphragm back
→ Poppet valve OPENS slightly
→ More high-pressure gas admitted

RESULT:
Self-regulating equilibrium maintains
CONSTANT OUTPUT PRESSURE
regardless of input pressure changes
→ Cylinder half-full or completely full:
   same output pressure delivered to flowmeters

---

Specific Regulators in Anaesthesia Machine

Critical design point: E-cylinder regulator output (~40–45 psig) is set below pipeline supply (50–55 psig). This ensures the machine always draws from the pipeline, automatically preserving the E-cylinder for emergency use without any manual switching.

---

Safety Features of Pressure Regulators

• Safety relief valve (blow-off valve): Opens if regulator fails and output pressure rises above safe limit — prevents explosion/equipment damage
• Pressure gauge upstream and downstream: Allows monitoring of both cylinder/pipeline pressure and regulated output pressure
• Non-adjustable output (factory-set spring): Prevents operator error in pressure setting

---

Quick Summary — Pressure Reducing Valve

╔═══════════════════════════════════════════════════════════╗
║ Purpose: Converts high variable P → constant low P        ║
║ E-cylinder O₂: 13,700 kPa → regulated to 40–45 psig      ║
║ Pipeline: 50–55 psig → second stage → 14–26 psig          ║
║ Mechanism: Diaphragm + spring + poppet valve              ║
║ Two-stage regulator = better constant output               ║
║ E-cyl output (40-45 psig) < Pipeline (50-55 psig)         ║
║ → Machine uses pipeline preferentially ← KEY SAFETY       ║
║ Safety relief valve: prevents pressure build-up failure    ║
╚═══════════════════════════════════════════════════════════╝

---

---

Q4 — LINK-25 PROPORTIONING SYSTEM

Introduction

---

Why is it Needed?

PROBLEM:
If anaesthetist accidentally:
→ Increases N₂O flow too much, OR
→ Decreases O₂ flow too much
→ N₂O:O₂ ratio exceeds 3:1
→ FiO₂ < 21% → HYPOXIC MIXTURE → patient hypoxia → death

SOLUTION: Link-25
→ Mechanically links N₂O and O₂ flow controls
→ Prevents N₂O:O₂ ratio from ever exceeding 3:1
→ Minimum O₂ = 25% at all times

---

Mechanism — Detailed

LINK-25 MECHANICAL CHAIN SYSTEM:

        N₂O Flow Control Valve
        (Sprocket: 29 TEETH)
               │
               │ ←── METAL CHAIN LINK ──→
               │                          │
        O₂ Flow Control Valve
        (Sprocket: 14 TEETH)

GEAR RATIO:  29 ÷ 14 = 2.07 : 1

SCENARIO A — Operator turns up N₂O:
→ N₂O sprocket (29T) rotates 1 full turn
→ Chain transmits motion to O₂ sprocket (14T)
→ O₂ sprocket rotates 29/14 = 2.07 turns
→ O₂ flow control valve opens MORE
→ O₂ flow AUTOMATICALLY INCREASES
→ N₂O:O₂ ratio cannot exceed 3:1 ✓

SCENARIO B — Operator turns down O₂:
→ O₂ sprocket (14T) rotates
→ Chain rotates N₂O sprocket (29T)
→ N₂O flow control valve CLOSES
→ N₂O flow AUTOMATICALLY DECREASES
→ Ratio maintained ≤ 3:1 ✓

SCENARIO C — Independent adjustment within safe range:
→ If O₂ is increased (without N₂O change):
   → Chain allows slack movement (no N₂O forced change)
   → Only LIMITING occurs, not linking in safe direction

---

Key Properties

---

What Link-25 Does NOT Protect Against

LIMITATIONS (Critical for exam):

1. Third gas dilution:
   If Air, He, or CO₂ is added to the N₂O+O₂ mix:
   → Link-25 only governs N₂O:O₂ ratio
   → Third gas dilutes the total mix
   → FiO₂ can fall below 25% despite Link-25

2. Pipeline crossover:
   If N₂O is inadvertently supplied in O₂ pipeline:
   → Link-25 sees "O₂ pressure" = high (actually N₂O)
   → Allows N₂O flow freely
   → Patient receives hypoxic/pure N₂O mixture

3. Mislabelled cylinders:
   → Link-25 cannot identify gas composition

4. O₂ flowmeter tube cracked upstream of manifold:
   → O₂ leaks before reaching patient
   → FiO₂ falls despite Link-25

SAFEGUARD THAT CATCHES ALL THE ABOVE:
→ O₂ ANALYSER (placed in breathing circuit)

---

Comparison: Link-25 vs S-ORC

---

Quick Summary — Link-25

╔═══════════════════════════════════════════════════════════╗
║ Link-25 = mechanical chain linking N₂O and O₂ controls   ║
║ Sprockets: N₂O = 29 teeth; O₂ = 14 teeth                 ║
║ Ensures: minimum FiO₂ = 25%; max N₂O:O₂ = 3:1           ║
║ Entirely MECHANICAL — no electricity needed               ║
║ Does NOT protect against: 3rd gas, pipeline crossover     ║
║ LAST RESORT protection: O₂ analyser in breathing circuit  ║
╚═══════════════════════════════════════════════════════════╝

---

---

Q5 — ROLE OF HUMIDIFICATION IN ANAESTHESIA PRACTICE

Introduction

---

Normal Airway Physiology

INSPIRED AIR (ambient):
Temperature: ~22°C | Humidity: ~10 mg H₂O/L (50% RH)
              │
              ▼
NOSE/NASOPHARYNX:
Warms to 34°C | Humidifies to 80% RH (34 mg/L)
              │
              ▼
TRACHEA (Isothermic Saturation Boundary — ISB):
Warms to 37°C | Humidifies to 100% RH (44 mg/L)
              │
              ▼
ALVEOLI: Gas exchange at 37°C, 100% RH

ON EXPIRATION:
Upper airway RECOVERS ~70% of moisture and heat
(heat and moisture exchange mechanism)

---

Effects of Dry, Cold Gases During Anaesthesia

DRY COLD GAS DELIVERED VIA ETT
              │
    ┌─────────┼──────────────────┐
    ▼         ▼                  ▼
Ciliary    Mucous          Epithelial
Dysfunction  Inspissation    Damage
    │         │                  │
    ▼         ▼                  ▼
↓Mucociliary  Secretion       Bronchial
clearance    plugging →       inflammation
             Atelectasis      Ulceration
              │
              ▼
    Postoperative complications:
    Pneumonia, atelectasis, prolonged ventilation

• Absolute humidity <26 mg/L → ciliary motility impaired
• Absolute humidity <10 mg/L → ciliary activity ceases completely
• Heat loss: 15–30% of total metabolic heat lost via respiratory tract
• Water loss: 200–400 mL/day via respiratory tract in non-humidified ventilation

---

Methods of Humidification in Anaesthesia

A. Passive Humidifiers — Heat and Moisture Exchangers (HME)

PRINCIPLE:
During EXPIRATION:
→ Warm, humid exhaled gas passes through HME
→ Moisture condenses on hygroscopic membrane
→ Heat stored in membrane

During INSPIRATION:
→ Cool dry fresh gas passes through HME
→ Absorbs stored moisture and heat
→ Delivered to patient warmed and humidified

Net effect:
→ Passive recovery of 70% of exhaled moisture
→ No external power/water supply needed

• Simple, disposable, no power needed
• Reduces circuit contamination (built-in filter in HMEF)
• Cost-effective
• Reduces infection transmission

• Adds deadspace (50–100 mL) — significant in neonates, small children
• Adds circuit resistance — increased work of breathing in spontaneous ventilation
• Insufficient for very long cases (>24 hrs) or profusely secreting patients
• Efficiency drops with large tidal volumes or very high respiratory rates
• Contraindicated: bloody/copious secretions (blocks filter)

---

B. Active Humidifiers

MECHANISM:
Fresh gas flows over/through heated water bath
→ Gas picks up water vapour
→ Delivered at 37–40°C, 100% RH (44 mg/L)

Heated wire breathing circuit:
→ Warms circuit walls
→ Prevents condensation ("rain-out") in tubing

• Near-physiological humidity (44 mg/L)
• Suitable for prolonged ventilation (ICU, long cases)
• No deadspace added

• Risk of thermal burns (overheating → gas >42°C)
• Risk of waterlogging (condensate in circuit → patient or ventilator damage)
• Requires power supply and water reservoir
• More complex setup; infection risk from water reservoir
• Adds weight to breathing circuit

---

C. Low Flow Anaesthesia as Humidification Method

• Rebreathed exhaled gas is warm and humid
• At FGF 0.5–1 L/min → inspired RH approaches 80–100%
• Most physiological humidification during GA — no device needed
• This is one of the major physiological advantages of LFA

---

Recommended Standards

---

Anaesthesia Implications — Summary

---

Quick Summary — Humidification

╔═══════════════════════════════════════════════════════════╗
║ Normal tracheal humidity: 44 mg/L at 37°C (100% RH)     ║
║ ISB (isothermic saturation boundary): normally at carina  ║
║ HME: passive, 70% recovery, adds 50–100 mL deadspace     ║
║ HMEF: HME + filter → best for ICU/contamination risk     ║
║ Active humidifier: 44 mg/L; risk = burns + waterlogging   ║
║ LFA: most physiological humidification during GA          ║
║ Neonates: active humidifier (HME deadspace too large)    ║
╚═══════════════════════════════════════════════════════════╝

---

---

Q6 — CO₂ ABSORBENTS: TYPES, COMPOSITION, ADVANTAGES, DISADVANTAGES + AMSORB (June 2012, June 2022)

Introduction

---

Types and Composition

1. Soda Lime (Most widely used)

Step 1: CO₂ + H₂O → H₂CO₃ (carbonic acid)
Step 2: H₂CO₃ + 2NaOH → Na₂CO₃ + 2H₂O  (fast — NaOH catalyst)
Step 3: Na₂CO₃ + Ca(OH)₂ → CaCO₃↓ + 2NaOH  (NaOH regenerated)

NET REACTION:
CO₂ + Ca(OH)₂ → CaCO₃ + H₂O + HEAT

Products: Calcium carbonate (chalk) + Water + Heat

• Fresh (active): White (or pink — ethyl violet added)
• Exhausted: Purple/Violet (ethyl violet turns purple in acid environment of H₂CO₃)
• May partially recover colour overnight (NaOH redistribution — does NOT indicate functional recovery)

• Highly efficient CO₂ absorber
• Inexpensive, widely available
• Rapid reaction kinetics
• Well-established, decades of safe use

• Compound A formation: Sevoflurane + KOH/NaOH → fluoromethyl-hexafluoroisopropyl ether (Compound A) — nephrotoxic in rats; requires FGF >1 L/min with sevoflurane (FDA recommendation)
• Carbon monoxide (CO) production: Desiccated soda lime + desflurane/isoflurane/enflurane → CO → carboxyhaemoglobinaemia ("Monday morning" phenomenon — machine left running over weekend dries out absorber)
• Exothermic heat released during absorption — can ignite in rare circumstances
• Dust production — silica added to minimise but not eliminate
• Strong alkali — caustic if direct contact with mucosal surfaces

---

2. Baralyme (Barium Hydroxide Lime) — Historical

• Ba(OH)₂·8H₂O (barium hydroxide octahydrate): 20%
• Ca(OH)₂: 80%
• No NaOH/KOH

---

3. Amsorb Plus (Modern Preferred Absorbent — June 2022)

CO₂ + Ca(OH)₂ + H₂O → CaCO₃ + 2H₂O

(Simpler reaction — no NaOH/KOH catalyst)
Slightly slower reaction than soda lime

• Slightly less efficient than soda lime (no NaOH catalyst → slower reaction)
• More expensive than traditional soda lime
• May require more frequent canister changes
• Less widely available in lower-resource settings

---

4. Lithium Hydroxide (LiOH)

• Used in space missions and submarine CO₂ scrubbing
• Very high CO₂ absorbing capacity per unit weight
• Not routinely used in clinical anaesthesia (expensive, caustic)

---

Comparison Table — All CO₂ Absorbents

---

CO₂ Absorbent Indicators Used in Clinical Practice

---

Practical Points (Anaesthesia Application)

SIGNS OF EXHAUSTED CO₂ ABSORBENT:
├── Colour change (white → purple/violet)
├── ↑ ETCO₂ despite adequate ventilation
├── ↑ inspired CO₂ (ETCO₂ never returns to zero)
├── Patient: ↑ respiratory rate (hypercapnia drive)
├── Hot canister (reaction slowing but residual heat)
└── Crumbly/dusty granules when changed

WHEN TO CHANGE:
→ When 2/3 of canister changes colour
→ After use for prolonged cases (>6–8 hours low flow)
→ If circuit contaminated
→ Routinely at start of day (do NOT rely on colour alone)

---

Quick Summary — CO₂ Absorbents

╔══════════════════════════════════════════════════════════════╗
║ Soda lime: Ca(OH)₂ 94% + NaOH 5% + KOH 1%                  ║
║ 1 kg soda lime absorbs ~120 L CO₂                            ║
║ Reaction: CO₂ + Ca(OH)₂ → CaCO₃ + H₂O + HEAT               ║
║ Indicator: White (fresh) → Purple/Violet (exhausted)         ║
║ Colour recovery overnight ≠ functional recovery              ║
║ Amsorb: Ca(OH)₂ ONLY — NO NaOH/KOH = NO Compound A, NO CO  ║
║ Amsorb = PREFERRED modern absorbent (safer with all agents)  ║
║ Compound A: Sevo + NaOH/KOH → use Amsorb OR FGF >1 L/min   ║
║ CO: Desiccated soda lime + desflurane = "Monday morning"     ║
║ Baralyme: WITHDRAWN (fire risk with dry absorbent + sevo)    ║
╚══════════════════════════════════════════════════════════════╝

---

---

Q7 — SCAVENGING IN OT: DEFINITION, FOUR BASIC PARTS, HAZARDS (Dec 2012)

Introduction

• Chronic OT exposure to trace anaesthetic gases is associated with significant occupational health hazards
• NIOSH (National Institute for Occupational Safety and Health, USA) recommended exposure limits:
  • N₂O: < 25 ppm (time-weighted average)
  • Halogenated agents: < 2 ppm (or <0.5 ppm if used with N₂O)

---

Sources of Waste Anaesthetic Gas in OT

SOURCES OF OT POLLUTION:
├── APL (pop-off) valve exhaust — MAIN source during spontaneous breathing
├── Ventilator relief valve — MAIN source during IPPV
├── Circuit leaks (connections, ETT cuff, face mask)
├── Patient exhalation during recovery (residual agent)
├── Filling and handling of vaporisers
└── Checking circuits before use

---

THE FOUR BASIC PARTS OF A SCAVENGING SYSTEM

WASTE GAS
   │
   ▼
┌──────────────────────────────────────────────────────┐
│ PART 1: GAS COLLECTING ASSEMBLY                      │
│  Captures gas at source                              │
└──────────────────────┬───────────────────────────────┘
                       │
                       ▼
┌──────────────────────────────────────────────────────┐
│ PART 2: TRANSFER TUBING                              │
│  Conveys gas from collecting assembly                │
│  to scavenging interface                             │
└──────────────────────┬───────────────────────────────┘
                       │
                       ▼
┌──────────────────────────────────────────────────────┐
│ PART 3: SCAVENGING INTERFACE                         │
│  (MOST IMPORTANT safety component)                   │
│  Protects patient's breathing circuit from           │
│  negative/positive pressure from disposal system     │
└──────────────────────┬───────────────────────────────┘
                       │
                       ▼
┌──────────────────────────────────────────────────────┐
│ PART 4: GAS DISPOSAL SYSTEM                          │
│  Active or passive — removes gas from OT             │
└──────────────────────────────────────────────────────┘

---

Part 1 — Gas Collecting Assembly

• Collects waste gas directly from the machine's relief valves
• Sources: APL (pop-off) valve + ventilator pressure relief valve
• Connected directly to these ports via 30 mm connectors
• 30 mm connectors (not 22 mm or 15 mm) used specifically for scavenging to prevent accidental connection to breathing circuit — ISO mandated distinction

---

Part 2 — Transfer Tubing

• Wide-bore (30 mm) tubing connecting collecting assembly to the interface
• Must be: smooth-walled (low resistance), wide enough (low resistance), non-collapsible
• Should NOT have long runs of narrow tubing (back-pressure risk)
• Colour: typically yellow (international standard) for easy identification

---

Part 3 — Scavenging Interface (Most Important)

• Positive pressure from disposal system (gas pushed back into circuit → barotrauma)
• Negative pressure from active disposal (suction applied to circuit → pneumothorax, circuit collapse)

A. Open Interface (Passive with reservoir bag)

Transfer tubing → OPEN reservoir bag
                       │
                 Vents to atmosphere
                 or passive exhaust

No pressure protection needed (open to air)
→ Simple, cheap
→ Risk: OT pollution if reservoir overflows

B. Closed Interface (Active system — STANDARD)

Transfer tubing → CLOSED interface box
                       │
          ┌────────────┴──────────────┐
          │                           │
   Positive Pressure         Negative Pressure
   Relief Valve              Relief Valve
   (opens if gas backs       (admits room air if
   up → vents to room        vacuum too strong →
   before reaching           prevents siphoning
   patient circuit)          from patient circuit)
          │
          ▼
    Active vacuum / disposal

• Positive pressure relief valve (APL on interface): Opens if downstream disposal is blocked → vents gas to room rather than back-pressuring patient circuit
• Negative pressure relief valve: Admits room air if vacuum exceeds safe level → prevents circuit collapse/siphoning from patient

---

Part 4 — Gas Disposal System

---

HAZARDS OF SCAVENGING SYSTEMS

A. Hazards from Scavenging System ITSELF

B. Hazards from INADEQUATE Scavenging (OT Pollution)

CHRONIC EXPOSURE TO TRACE ANAESTHETIC GASES:

N₂O exposure > 25 ppm:
├── Spontaneous abortion ↑ (exposed OT staff)
├── Bone marrow depression (megaloblastic anaemia)
├── Peripheral neuropathy (B₁₂ inactivation)
├── Teratogenicity (animal models)
└── Cognitive impairment (chronic exposure)

Volatile agents (halogenated) > 2 ppm:
├── Hepatotoxicity (halothane — occupational hepatitis)
├── Renal toxicity (methoxyflurane — historic)
├── Mutagenicity concerns
└── Fatigue, headache, cognitive impairment (acute)

NIOSH Limits:
N₂O alone: < 25 ppm
Halogenated alone: < 2 ppm
N₂O + halogenated: < 25 ppm N₂O + < 0.5 ppm halogenated

---

Monitoring OT Pollution (Passive Dosimetry Badges)

• Infrared spectroscopy devices — measure N₂O and volatile agent concentrations
• NIOSH-approved passive dosimetry badges worn by OT staff
• Regular OT air sampling recommended if scavenging system suspected inadequate

---

Quick Summary — Scavenging

╔══════════════════════════════════════════════════════════════╗
║ WAGD = Waste Anaesthetic Gas Disposal                        ║
║ NIOSH limits: N₂O <25 ppm; Halogenated <2 ppm               ║
║ 4 PARTS: Collecting Assembly → Transfer Tubing →            ║
║          Scavenging Interface → Disposal System              ║
║ INTERFACE = most important safety component                  ║
║ Interface has: +ve relief valve (barotrauma prevention)      ║
║               -ve relief valve (siphoning prevention)        ║
║ 30 mm connectors: cannot connect to 22/15 mm breathing circuit║
║ Active: hospital vacuum — most reliable                      ║
║ Passive: building exhaust — cheap but less reliable          ║
║ N₂O chronic exposure: megaloblastic anaemia, spontaneous     ║
║ abortion, neuropathy (B₁₂ inactivation → methionine         ║
║ synthase inhibition)                                          ║
╚══════════════════════════════════════════════════════════════╝

---

MASTER SUMMARY — ALL 7 QUESTIONS

---

Questions at a Glance

---

Top Examiner-Bait Points Across This Module

1. Rotameter: "O₂ tube must be downstream" — single most tested design safety principle
2. LFA: Compound A (sevo + NaOH lime) vs CO (dry soda lime + desflurane) — distinguish clearly
3. Pressure reducing valve: E-cylinder output LESS than pipeline pressure — machine uses pipeline preferentially
4. Link-25: Does NOT protect against third gas dilution or pipeline crossover — examiner's trap
5. Humidification: ISB concept + HME deadspace problem in neonates — high viva yield
6. CO₂ absorbents: Amsorb has NO NaOH/KOH = no Compound A, no CO — this is the entire point of Amsorb
7. Scavenging: Interface has BOTH +ve AND -ve relief valves — bidirectional protection; N₂O → B₁₂ inhibition → methionine synthase → megaloblastic picture

---

APL VALVE (ADJUSTABLE PRESSURE-LIMITING VALVE)

DNB Final Anaesthesia | 10-Mark Distinction-Level Answer

---

1. INTRODUCTION

• It is the single most frequently manipulated component of the anaesthesia circuit during manual ventilation
• Its malfunction (stuck closed or stuck open) can cause life-threatening barotrauma or hypoventilation
• Understanding it is fundamental to safe conduct of anaesthesia

"The APL valve is the guardian of airway pressure — open too much, the patient hypoventilates; closed too much, the patient suffers barotrauma."

---

2. APPLIED ANATOMY — POSITION IN CIRCLE SYSTEM

Components of the Circle Breathing System (Barash 9e / Miller 10e)

FRESH GAS
INLET
    │
    ▼
┌──────────────────────────────────────────────────────────┐
│          CIRCLE BREATHING SYSTEM                          │
│                                                           │
│  FGI ──→ [INSPIRATORY UNIDIRECTIONAL VALVE]              │
│                │                                          │
│                │ (Inspiratory limb)                       │
│                ▼                                          │
│         ┌─────────────┐                                   │
│         │  Y-PIECE    │ ←────── PATIENT                  │
│         └─────────────┘                                   │
│                │                                          │
│                │ (Expiratory limb)                        │
│                ▼                                          │
│  [EXPIRATORY UNIDIRECTIONAL VALVE]                        │
│                │                                          │
│                ▼                                          │
│  ┌─────────────────────────────┐                         │
│  │     CO₂ ABSORBER (Soda lime)│                         │
│  └─────────────────────────────┘                         │
│                │                                          │
│                ▼                                          │
│  ┌─────────────────────────────┐                         │
│  │    RESERVOIR BAG            │                          │
│  └─────────────────────────────┘                         │
│                │                                          │
│                ▼                                          │
│  ┌─────────────────────────────┐                         │
│  │  ◄── APL VALVE ──►         │ → TO SCAVENGING          │
│  │  (Pop-off / Overflow)       │                          │
│  └─────────────────────────────┘                         │
└──────────────────────────────────────────────────────────┘

1. A unidirectional valve must exist between patient and reservoir bag on both inspiratory and expiratory limbs
2. APL valve must NOT be located between the patient and the inspiratory valve
3. Fresh gas inflow must NOT enter between the expiratory valve and the patient

---

3. STRUCTURE AND MECHANISM

Structural Components

TO SCAVENGING SYSTEM
         ↑
    ┌────┴──────────────────────────────┐
    │         APL VALVE                 │
    │                                   │
    │  ┌─────────────────────────┐      │
    │  │   EXHAUST PORT          │      │ ← Outlet to scavenging
    │  │   (to scavenging)       │      │
    │  └──────────┬──────────────┘      │
    │             │                     │
    │  ┌──────────┴──────────────┐      │
    │  │   DISC VALVE / POPPET   │      │ ← Lifted off seat by
    │  │   (sealing disc)        │      │   circuit pressure
    │  └──────────┬──────────────┘      │
    │             │                     │
    │  ┌──────────┴──────────────┐      │
    │  │   SPRING               │      │ ← Resists opening;
    │  │   (compression spring)  │      │   tension set by dial
    │  └──────────┬──────────────┘      │
    │             │                     │
    │  ┌──────────┴──────────────┐      │
    │  │   ADJUSTING CONTROL     │      │ ← Rotating knob/dial
    │  │   KNOB / DIAL           │      │   operated by anaesthetist
    │  └─────────────────────────┘      │
    │                                   │
    └───────────────────────────────────┘
         ↑
    FROM BREATHING CIRCUIT

Mechanism of Operation

CIRCUIT PRESSURE BUILDS (from FGF + exhalation)
              │
              ▼
When circuit pressure EXCEEDS spring tension:
              │
              ▼
Disc valve LIFTS OFF its seat
              │
              ▼
Gas VENTS through exhaust port → scavenging system
              │
              ▼
Circuit pressure FALLS back to set level
              │
              ▼
Spring CLOSES disc valve again
              │
              ▼
Equilibrium maintained at set opening pressure

• Turn clockwise (tighten): Compresses spring more → higher pressure needed to open → circuit pressure RISES → for controlled/assisted ventilation
• Turn anticlockwise (loosen): Reduces spring tension → lower pressure opens valve → circuit pressure FALLS → for spontaneous ventilation

---

4. OPERATING PRESSURE SETTINGS

Clinical pearl: During manual controlled ventilation, set APL at 15–20 cmH₂O. Squeeze reservoir bag until chest rises. This limits airway pressure to a safe level while delivering adequate tidal volume (~7–8 mL/kg).

---

5. RELATIONSHIP WITH FRESH GAS FLOW (FGF)

FGF delivered to circuit continuously:

If FGF > Patient's minute ventilation uptake:
→ Excess gas accumulates in circuit
→ Circuit pressure RISES
→ APL valve OPENS → vents excess gas
→ Circuit pressure maintained at set level

If FGF = Patient's uptake (closed circuit):
→ No excess gas
→ APL valve remains CLOSED
→ No gas vented

If FGF < Patient's uptake:
→ Gas deficit → reservoir bag deflates
→ Patient cannot inhale adequate TV
→ Indicates inadequate FGF setting

• Semiclosed (APL partially open, some rebreathing → standard clinical use)
• Closed (APL fully closed, complete rebreathing, FGF = metabolic uptake)
• Semiopen (APL fully open, high FGF, minimal rebreathing)

---

6. APL VALVE IN DIFFERENT CLINICAL SCENARIOS

A. During Induction — Bag-Mask Ventilation

Patient apnoeic → manual mask ventilation
APL: Set to 15–20 cmH₂O
→ Gentle squeeze of reservoir bag
→ Gas flows to lungs (pressure builds)
→ When pressure = APL setting → valve opens → excess vents
→ Controlled peak airway pressure delivered
→ Prevents gastric insufflation (keep PAP <20 cmH₂O)

B. Transition to Mechanical Ventilator

When switching from Manual Bag → Mechanical Ventilator:

BAG/VENT selector switch:
→ "BAG" position: APL valve IN circuit; reservoir bag in use
→ "VENT" position: APL valve EXCLUDED from circuit
                   Ventilator relief valve takes over
                   Reservoir bag bypassed

⚠ CRITICAL ERROR: Leaving APL valve CLOSED when switching to ventilator
→ If selector inadvertently left in BAG mode with APL closed
→ Both APL closed AND ventilator pressure builds
→ Extremely high circuit pressure → BAROTRAUMA

C. During Spontaneous Ventilation (Maintenance)

APL: Fully OPEN (anticlockwise, minimum spring tension)
→ Resistance to expiration = 1–3 cmH₂O only
→ Patient exhales freely
→ Excess FGF vents continuously during expiration
→ Reservoir bag fills slightly (visual breathing monitor)

D. During Emergence and Recovery

APL: Partially open → monitor spontaneous breathing return
→ As patient breathes spontaneously:
   Reservoir bag moves visibly (confirms ventilation)
→ Adjust APL to allow free spontaneous breathing
   while maintaining low level CPAP if desired (1–3 cmH₂O)

---

7. PRESSURE-VOLUME RELATIONSHIP (COMPLIANCE CURVE)

APL Valve Pressure-Volume Characteristics:

Circuit Pressure (cmH₂O)
     |
  60-|                    Hard limit
     |                   /
  40-|                  /
     |    APL opens     /
  20-|    ─────────────/──────────────── Set pressure
     |   /
  10-|  /
     | /
   2-|/ (closed state, minimal baseline pressure)
     |________________________
     0    Reservoir volume →

Flat portion: below set pressure → APL closed → pressure builds
Opening pressure: when exceeded → APL opens → pressure plateau

---

8. MALFUNCTIONS OF APL VALVE

A. APL Valve Stuck CLOSED / Forgot to Open

SCENARIO: APL closed during spontaneous ventilation
              │
              ▼
Exhaled gas CANNOT escape circuit
              │
              ▼
Circuit pressure RISES progressively
              │
              ▼
↑↑ Intrathoracic pressure → ↓VR → ↓CO → Hypotension
              │
              ▼
Tension pneumothorax (if continued)
              │
              ▼
Patient appears to be "breathing" but
reservoir bag does NOT deflate
→ DIAGNOSE: distended reservoir bag + ↑airway pressure alarm
              │
              ▼
MANAGEMENT:
→ Immediately OPEN APL valve
→ Manually deflate circuit via APL
→ IPPV support until patient recovers
→ Check for pneumothorax (CXR, ultrasound)

B. APL Valve Stuck OPEN / Completely Open During IPPV

SCENARIO: APL fully open during manual IPPV
              │
              ▼
Every squeeze of reservoir bag → gas escapes through APL
              │
              ▼
Insufficient pressure generated to inflate lungs
              │
              ▼
Patient: HYPOVENTILATION → Hypercapnia → Hypoxia
→ Reservoir bag feels soft, squeezes easily (no resistance)
→ No chest rise observed
→ ETCO₂ absent or falling
              │
              ▼
MANAGEMENT:
→ Increase APL tension (close partially)
→ Check for circuit disconnection (mimics this)
→ Switch to mechanical ventilator

C. APL Valve Incompetence (Valve Leak)

• Disc valve fails to seat completely at rest
• Allows continuous gas leak even when "closed"
• Results in inability to build adequate circuit pressure
• Detected by: circuit leak test pre-operatively
• Management: replace APL valve assembly

D. Partial Obstruction

• Debris/secretions in valve → intermittent sticking
• Unpredictable pressure buildup
• Detected during pre-use machine check

---

9. COMPARISON — APL VALVE vs VENTILATOR PRESSURE RELIEF VALVE

---

10. SPECIAL TYPES AND MODIFICATIONS

A. Pressure-Limiting APL (PEEP valve modification)

• Some APL valves have a PEEP function — maintain positive pressure at end-expiration
• Used in: spontaneously breathing patients requiring CPAP during anaesthesia
• Opening pressure set at 5–10 cmH₂O → provides CPAP

B. Integrated APL with BAG/VENT Selector

• Modern workstations integrate APL valve with the bag/ventilator selector switch
• Switching to VENT mode → APL valve automatically removed from circuit path
• Prevents common error of leaving APL in circuit during mechanical ventilation

C. Electronically Controlled APL (Modern Workstations)

• On GE Aisys, Dräger Zeus — APL valve function is electronically controlled
• Set via touch screen; pressure servo-controlled automatically
• Alarm generated if circuit pressure exceeds set APL limit

---

11. CLINICAL ERRORS INVOLVING APL VALVE — SAFETY POINTS

---

12. PRE-USE CHECK OF APL VALVE

□ APL valve moves freely — anticlockwise to open, clockwise to close
□ Test at FULLY OPEN: close patient port → squeeze bag lightly
  → circuit pressure should NOT exceed 3–5 cmH₂O (vents freely)
□ Test at CLOSED: close patient port → squeeze bag
  → circuit pressure should rise to >30 cmH₂O (holds pressure)
□ Confirm scavenging connection attached to APL exhaust port
□ Leak test: circuit sealed → APL closed → 30 cmH₂O → stable for 10 sec
□ Confirm APL left OPEN after testing (before patient connected)

---

QUICK REVISION SUMMARY BOX

╔══════════════════════════════════════════════════════════════════╗
║         APL VALVE — DNB DISTINCTION VIVA PEARLS                 ║
╠══════════════════════════════════════════════════════════════════╣
║ FULL NAME: Adjustable Pressure-Limiting valve                   ║
║ SYNONYMS: Pop-off valve | Overflow valve | Spill valve          ║
║ MECHANISM: Spring-loaded disc valve — spring tension = APL      ║
╠══════════════════════════════════════════════════════════════════╣
║ SETTINGS:                                                        ║
║ Spontaneous ventilation → FULLY OPEN → 1–3 cmH₂O               ║
║ Manual IPPV → PARTIALLY CLOSED → 15–20 cmH₂O                   ║
║ Closed circuit → FULLY CLOSED → 0 cmH₂O (no gas vented)        ║
║ Mechanical ventilation → APL EXCLUDED (BAG/VENT switch)         ║
╠══════════════════════════════════════════════════════════════════╣
║ MALFUNCTIONS:                                                    ║
║ Stuck CLOSED → barotrauma / pneumothorax / ↓CO → hypotension    ║
║ Stuck OPEN → hypoventilation → hypercapnia → hypoxia            ║
║ Incompetent (leaking) → unable to build circuit pressure        ║
╠══════════════════════════════════════════════════════════════════╣
║ POSITIONING RULES (Circle system):                               ║
║ APL must NOT be between patient and inspiratory valve            ║
║ APL must be on EXPIRATORY limb side                             ║
║ Connected to scavenging — NOT open to OT air                    ║
╠══════════════════════════════════════════════════════════════════╣
║ COMMON EXAM ERRORS TO AVOID:                                     ║
║ ✗ APL does NOT limit FiO₂ or agent concentration               ║
║ ✗ APL is NOT the same as the ventilator relief valve            ║
║ ✗ When switching to ventilator: APL is EXCLUDED from circuit    ║
║ ✗ APL open ≠ breathing circuit disconnected (mimic each other)  ║
║ ✗ Forgetting APL valve in CLOSED position after leak test        ║
╚══════════════════════════════════════════════════════════════════╝

---

---

CYLINDERS, PIPELINES, PISS, DISS & COLOUR CODING

DNB Final Anaesthesia | 10-Mark Distinction-Level Answer

---

1. INTRODUCTION

GAS SUPPLY SYSTEM — OVERVIEW

BULK LIQUID STORAGE (hospital)
        │
        ▼
CENTRAL PIPING SYSTEM
        │ ← DISS + Colour coding (wall outlet safety)
        ▼
ANAESTHESIA MACHINE PIPELINE INLET
(50–55 psig / 400 kPa)
        │
        ▼
INTERMEDIATE PRESSURE CIRCUIT → FLOWMETERS → PATIENT

BACKUP:
E-CYLINDERS
        │ ← PISS + Colour coding (cylinder safety)
        ▼
HIGH-PRESSURE REGULATOR → 40–45 psig
        │
        ▼
JOINS INTERMEDIATE PRESSURE CIRCUIT

---

2. MEDICAL GAS CYLINDERS

A. Types of Cylinders Used in Anaesthesia

---

B. Cylinder Construction

CYLINDER ANATOMY:
┌──────────────────────────┐
│  VALVE BLOCK (Top)       │ ← Contains: pressure gauge,
│  Pin Index holes         │   main on/off valve, PISS holes
│  Pressure relief device  │
├──────────────────────────┤
│                          │
│  CYLINDER BODY           │ ← Seamless steel / aluminium alloy
│  (high-strength alloy    │   Colour-coded shoulder
│   steel)                 │
│                          │
│  GAS CONTENTS:           │
│  O₂, N₂O, Air, CO₂, He  │
│                          │
└──────────────────────────┘

• Oxygen: Seamless chromium-molybdenum steel (high pressure)
• N₂O: Similar alloy steel
• Modern lighter cylinders: Aluminium + carbon fibre composite

• Located in valve block
• If internal pressure exceeds safe limit → disc ruptures → gas vents safely
• Prevents cylinder explosion in fire/overheating

---

C. Cylinder Content Calculation

Content (litres) = Cylinder pressure (bar) × Cylinder volume (litres)

E-cylinder full: 137 bar × 4.7 L = ~644 litres O₂

At 4 L/min flow: Duration = 644 ÷ 4 = ~161 minutes ≈ 2.7 hours

⚠ CRITICAL: When O₂ gauge reads 0 → cylinder TRULY EMPTY
(pressure falls linearly with gas usage — Boyle's Law)

N₂O exists as LIQUID + GAS in equilibrium at room temperature
Vapour pressure remains CONSTANT at ~51 bar (750 psig)
until ALL liquid has evaporated

→ Pressure gauge reads 750 psig whether cylinder is 100% full or 10% full
→ CANNOT gauge N₂O content from pressure alone!

CORRECT method: WEIGH the cylinder
Content (kg) = [Total weight – Tare weight (empty cylinder weight)]
1 kg liquid N₂O = ~500 litres N₂O gas

⚠ Tare weight (Tw) is stamped on the cylinder collar

"Oxygen Pressure → Boyle; N₂O → Weigh it boy"

---

D. Cylinder Pressures — Key Values

---

E. Cylinder Safety — Why E-Cylinder Pressure Regulator Output is Set BELOW Pipeline

E-cylinder regulator output: 40–45 psig
Pipeline supply pressure:    50–55 psig
                                │
                                ▼
Machine ALWAYS prefers PIPELINE (higher pressure)
→ E-cylinder preserved for emergencies
→ Automatic seamless switchover if pipeline fails

⚠ CRITICAL SCENARIO — Pipeline Crossover:
If N₂O accidentally supplied in O₂ pipeline (50 psig):
→ Turning on O₂ E-cylinder alone is INSUFFICIENT
→ Machine will still draw from pipeline (higher P)
→ MUST disconnect pipeline AND turn on E-cylinder

Pipeline (50 psig) > E-cylinder regulator (45 psig) → Pipeline used preferentially

---

3. HOSPITAL PIPELINE SUPPLY SYSTEM

A. How the Pipeline System Works

BULK LIQUID STORAGE TANK (outside hospital)
Liquid O₂ at -183°C (cryogenic)
            │
            ▼ (vaporised)
PRESSURE MANIFOLD SYSTEM
            │
            ▼
HOSPITAL PIPING NETWORK
(dedicated separate pipes for each gas)
            │
            ▼
OT WALL OUTLETS
(50–55 psig / 400 kPa)
            │
            ▼ (via DISS)
ANAESTHESIA MACHINE PIPELINE INLET

• All medical gases delivered at 400 kPa (50–55 psig) at wall outlet
• This is the normal operating pressure of the anaesthesia workstation intermediate-pressure circuit

B. Pipeline Supply Hazards (Historically documented)

In a suspected pipeline crossover: (1) Turn ON E-cylinder O₂, (2) DISCONNECT pipeline hose — BOTH steps mandatory. (Miller's 10e, Barash 9e)

---

4. PIN INDEX SAFETY SYSTEM (PISS)

Definition

Mechanism

HANGER YOKE ASSEMBLY:

    ╔═══════════════════════════╗
    ║   HANGER YOKE             ║
    ║                           ║
    ║   ●  ●  (2 METAL PINS)   ║ ← project outward
    ║   in specific positions   ║
    ║                           ║
    ║   Bodok seal washer       ║
    ╚═══════════════════════════╝
              ↕ fits only if pins match holes
    ╔═══════════════════════════╗
    ║   CYLINDER VALVE BLOCK    ║
    ║                           ║
    ║   ○  ○  (2 HOLES)        ║ ← specific positions per gas
    ║                           ║
    ╚═══════════════════════════╝

PIN POSITIONS — THE MOST IMPORTANT TABLE IN THIS TOPIC

╔═══════════════════════════════════════════════════════╗
║         PIN INDEX SAFETY SYSTEM — PIN POSITIONS       ║
╠══════════════════╦════════════════════════════════════╣
║ GAS              ║ PIN POSITIONS                      ║
╠══════════════════╬════════════════════════════════════╣
║ Oxygen           ║ 2  and  5                          ║
║ Nitrous Oxide    ║ 3  and  5                          ║
║ Cyclopropane     ║ 3  and  6                          ║
║ Air              ║ 1  and  5                          ║
║ CO₂              ║ 1  and  6                          ║
║ He/O₂ mixtures   ║ 2  and  4                          ║
║ CO₂/O₂ mixtures  ║ 1  and  6 (same as CO₂ if >7% CO₂)║
║ Ethylene         ║ 1  and  3                          ║
╚══════════════════╩════════════════════════════════════╝

PISS Pin Positions — Visual Map

Position reference on cylinder valve face:

    1    2    3
    ●    ●    ●    (top row)

    4    5    6
    ●    ●    ●    (bottom row)

O₂    = positions 2 + 5  → Top middle + Bottom middle
N₂O   = positions 3 + 5  → Top right + Bottom middle
Air   = positions 1 + 5  → Top left + Bottom middle
CO₂   = positions 1 + 6  → Top left + Bottom right

MNEMONIC FOR PISS PIN POSITIONS

"ON ACE" — Order: O₂, N₂O, Air, CO₂, Ethylene

Read as: "Oh-two-five, En-three-five, Ay-one-five, See-one-six" Repeat it like a phone number: 025 — 035 — 015 — 016

---

Limitations of PISS

PISS FAILS WHEN:
├── Pins are forcibly removed or broken
├── >1 Bodok seal washer used
│   (extra washer lifts cylinder away from yoke
│    → pins don't engage holes → wrong cylinder fits)
├── Gas mixtures >7% CO₂ share same pin as pure CO₂
│   → CO₂/O₂ mix could go into CO₂ yoke
└── Mislabelled cylinders (colour + label ignored)

Why NOT to use >1 washer: A well-documented cause of PISS failure — adds mechanical distance that allows wrong cylinder to seat. Always use EXACTLY ONE Bodok seal.

---

5. DIAMETER INDEX SAFETY SYSTEM (DISS)

Definition

Mechanism

PIPELINE HOSE → MACHINE INLET CONNECTION:

Each gas has a UNIQUE combination of:
  (1) Body diameter (thread size)
  (2) Nipple bore diameter (internal)

These two dimensions vary INVERSELY for each gas:
→ As body diameter ↑, nipple bore ↓ (and vice versa)
→ Each combination is physically UNIQUE to one gas

O₂ hose connector ──X──→ N₂O machine inlet
(different diameter)    (physically impossible to connect)

DISS vs PISS — Side-by-Side Comparison

╔═════════════════════╦═════════════════════╦═════════════════════╗
║ FEATURE             ║ PISS                ║ DISS                ║
╠═════════════════════╬═════════════════════╬═════════════════════╣
║ Full name           ║ Pin Index Safety    ║ Diameter Index      ║
║                     ║ System              ║ Safety System       ║
╠═════════════════════╬═════════════════════╬═════════════════════╣
║ Used for            ║ E-CYLINDERS         ║ PIPELINE hoses      ║
╠═════════════════════╬═════════════════════╬═════════════════════╣
║ Mechanism           ║ Pin + hole pattern  ║ Unique threaded     ║
║                     ║ (physical fit)      ║ diameter per gas    ║
╠═════════════════════╬═════════════════════╬═════════════════════╣
║ Connector location  ║ Hanger yoke on      ║ Wall outlet +       ║
║                     ║ machine             ║ machine inlet       ║
╠═════════════════════╬═════════════════════╬═════════════════════╣
║ Established by      ║ Compressed Gas      ║ Compressed Gas      ║
║                     ║ Association (CGA)   ║ Association (CGA)   ║
╠═════════════════════╬═════════════════════╬═════════════════════╣
║ Also called         ║ —                   ║ Non-interchangeable ║
║                     ║                     ║ screw thread (NIST) ║
╠═════════════════════╬═════════════════════╬═════════════════════╣
║ Limitations         ║ Pin removal, extra  ║ Manufacturer-       ║
║                     ║ washer              ║ specific (quick-    ║
║                     ║                     ║ connect not always  ║
║                     ║                     ║ cross-brand safe)   ║
╚═════════════════════╩═════════════════════╩═════════════════════╝

"Cylinders get PINS; Pipelines get DIAMETERS" Or: "C-P-D: Cylinder-Pin, D-Pipeline-Diameter"

Additional Pipeline Connection Safety

• Quick-connect fittings: Gas-specific within same manufacturer but NOT necessarily interchangeable between brands
  • Ohmeda Diameter Index ≠ Chemetron ≠ Puritan Bennett quick-connects for same gas
  • Caution when mixing different manufacturer wall outlets and machine hoses
• NIST (Non-Interchangeable Screw Thread) connectors — UK equivalent of DISS
• Pipeline hoses in UK are permanently attached to the machine — cannot be detached and swapped

---

6. COLOUR CODING OF MEDICAL GAS CYLINDERS AND PIPELINES

International Colour Coding (ISO 32 Standard)

╔══════════════════════════════════════════════════════════════════╗
║           COLOUR CODING — ISO 32 (INTERNATIONAL)               ║
╠══════════════╦══════════════════╦═══════════════╦══════════════╣
║ GAS          ║ CYLINDER BODY    ║ CYLINDER      ║ PIPELINE     ║
║              ║ COLOUR           ║ SHOULDER      ║ HOSE COLOUR  ║
╠══════════════╬══════════════════╬═══════════════╬══════════════╣
║ Oxygen       ║ White            ║ White         ║ White        ║
║ Nitrous Oxide║ Blue             ║ Blue          ║ Blue         ║
║ Medical Air  ║ White            ║ Black+White   ║ Black/White  ║
║ CO₂          ║ Grey             ║ Grey          ║ Grey         ║
║ Helium       ║ Brown            ║ Brown         ║ —            ║
║ N₂ (nitrogen)║ Black            ║ Black         ║ —            ║
║ Entonox      ║ Blue             ║ Blue+White    ║ —            ║
║              ║                  ║ (quartered)   ║              ║
╚══════════════╩══════════════════╩═══════════════╩══════════════╝

Indian Colour Coding (BIS 7885 — Bureau of Indian Standards)

╔══════════════════════════════════════════════════════════╗
║        COLOUR CODING — INDIA (BIS 7885)                 ║
╠══════════════╦══════════════════════════════════════════╣
║ GAS          ║ CYLINDER COLOUR (India)                  ║
╠══════════════╬══════════════════════════════════════════╣
║ Oxygen       ║ BLACK body + WHITE shoulder              ║
║ Nitrous Oxide║ BLUE (same as ISO)                       ║
║ CO₂          ║ GREY (same as ISO)                       ║
║ Medical Air  ║ GREY body + BLACK+WHITE shoulder         ║
║ Cyclopropane ║ ORANGE                                   ║
╚══════════════╩══════════════════════════════════════════╝

Critical exam distinction:

• In the UK/Europe/ISO: O₂ cylinder = WHITE
• In India (BIS): O₂ cylinder = BLACK body + WHITE shoulder
• In USA: No FDA standard for cylinder colour — always READ THE LABEL

MNEMONIC FOR ISO COLOUR CODING

"WBBGB" = White, Blue, Black-white, Grey, Brown = O₂, N₂O, Air, CO₂, He

---

7. PRESSURE SECTIONS OF THE ANAESTHESIA MACHINE

╔══════════════════════════════════════════════════════════════════╗
║            THREE PRESSURE SECTIONS                              ║
╠══════════════╦══════════════════╦═══════════════════════════════╣
║ SECTION      ║ PRESSURE RANGE   ║ COMPONENTS                   ║
╠══════════════╬══════════════════╬═══════════════════════════════╣
║ HIGH-        ║ 0–13,700 kPa     ║ E-cylinders                  ║
║ PRESSURE     ║ (0–2000 psig)    ║ High-pressure regulators     ║
║              ║                  ║ Cylinder pressure gauges     ║
╠══════════════╬══════════════════╬═══════════════════════════════╣
║ INTERMEDIATE ║ 275–400 kPa      ║ Pipeline inlets (DISS)       ║
║ PRESSURE     ║ (40–55 psig)     ║ Regulated cylinder output    ║
║              ║                  ║ O₂ failure warning device    ║
║              ║                  ║ O₂ failure cutoff valve      ║
║              ║                  ║ Second-stage regulators      ║
║              ║                  ║ Flow control valves          ║
╠══════════════╬══════════════════╬═══════════════════════════════╣
║ LOW-         ║ Just above atm   ║ Flowmeters / rotameters      ║
║ PRESSURE     ║ pressure         ║ Vaporiser manifold           ║
║              ║                  ║ Common gas outlet            ║
║              ║                  ║ Breathing circuit            ║
╚══════════════╩══════════════════╩═══════════════════════════════╝

---

8. BODOK SEAL — THE OVERLOOKED SAFETY COMPONENT

BODOK SEAL (Non-interchangeable washer):
→ Neoprene/rubber washer between cylinder valve + hanger yoke
→ Creates a GAS-TIGHT seal under compression
→ ONE seal per yoke connection (ONLY ONE)
→ Colour-coded: O₂ = green (some manufacturers)

FUNCTIONS:
├── Gas-tight seal: prevents leakage of high-pressure gas
├── Non-interchangeable between different gas connections
└── Safety: ensures correct seating of cylinder in yoke

DANGERS:
├── Missing seal → gas leak → incorrect pressure reading
├── >1 seal → PISS fails (cylinder sits too far from yoke)
└── Cracked/damaged seal → slow gas leak → cylinder empties

---

9. COMPLETE SAFETY HIERARCHY — GAS SUPPLY

MULTI-LAYERED SAFETY:

Layer 1: COLOUR CODING
→ Visual identification of gas before connection

Layer 2: PISS (cylinders) / DISS (pipelines)
→ Physical prevention of wrong connection

Layer 3: PRESSURE GAUGES
→ Confirms appropriate supply pressure

Layer 4: CHECK VALVES
→ Prevents backflow and cross-contamination

Layer 5: O₂ FAILURE WARNING DEVICE (Ritchie Whistle)
→ Audible alarm on O₂ pressure failure

Layer 6: O₂ FAILURE CUTOFF VALVE
→ N₂O automatically shut off

Layer 7: PROPORTIONING SYSTEMS (Link-25 / S-ORC)
→ Minimum 25% O₂ in N₂O mixture

Layer 8: O₂ ANALYSER (LAST LINE OF DEFENCE)
→ Measures actual FiO₂ delivered to patient

If ALL layers fail → Clinician vigilance + O₂ analyser alarm

---

10. QUICK REVISION SUMMARY BOX

╔══════════════════════════════════════════════════════════════════╗
║    CYLINDERS, PISS, DISS, COLOUR CODING — VIVA PEARLS           ║
╠══════════════════════════════════════════════════════════════════╣
║  PISS PIN POSITIONS (Master mnemonic: 025 — 035 — 015 — 016)   ║
║  O₂ = 2+5 | N₂O = 3+5 | Air = 1+5 | CO₂ = 1+6                ║
║                                                                  ║
║  COLOUR CODES (ISO): "White O₂, Blue N₂O, B+W Air, Grey CO₂"   ║
║  India (BIS): O₂ = BLACK body + WHITE shoulder                  ║
║  USA: NO standard colour → always READ THE LABEL                ║
╠══════════════════════════════════════════════════════════════════╣
║  PISS = Cylinders (PINS) | DISS = Pipelines (DIAMETERS)         ║
║  "Cylinders get Pins; Pipelines get Diameters"                  ║
╠══════════════════════════════════════════════════════════════════╣
║  CYLINDER CONTENTS:                                              ║
║  O₂ → Compressed gas → Pressure ∝ content (Boyle's Law)        ║
║  N₂O → Liquid + vapour → Pressure CONSTANT until liquid gone   ║
║  N₂O content → WEIGH cylinder (Tare weight stamped on collar)  ║
║  E-cylinder O₂: full = 2000 psig (137 bar) = ~644 litres       ║
╠══════════════════════════════════════════════════════════════════╣
║  PIPELINE PRESSURE: 400 kPa (50–55 psig) — all gases           ║
║  E-cylinder regulator: 40–45 psig < pipeline (50–55 psig)       ║
║  → Machine uses PIPELINE preferentially                         ║
║  → Pipeline crossover: TURN ON cylinder + DISCONNECT pipeline   ║
╠══════════════════════════════════════════════════════════════════╣
║  PISS FAILURE: pin removal / >1 Bodok seal / mislabelled cyl   ║
║  Bodok seal: EXACTLY ONE per yoke connection                    ║
╠══════════════════════════════════════════════════════════════════╣
║  COMMON EXAM MISTAKES:                                           ║
║  ✗ N₂O pressure gauge indicates content — IT DOES NOT           ║
║  ✗ Turning on O₂ cylinder corrects pipeline crossover — NO     ║
║    (must ALSO disconnect pipeline)                              ║
║  ✗ Confusing PISS (cylinders) with DISS (pipelines)            ║
║  ✗ US O₂ = green (cylinder colour) — ISO O₂ = WHITE            ║
║  ✗ India O₂ = black + white shoulder ≠ ISO white cylinder      ║
╚══════════════════════════════════════════════════════════════════╝

---

---

PROPOFOL

DNB Final Anaesthesia | 10-Mark Distinction-Level Answer

---

1. INTRODUCTION

        OH
        │
    CH(CH₃)₂    CH(CH₃)₂
         \         /
          ─benzene ring─
              (phenol nucleus)

= 2,6-di-isopropylphenol
Molecular weight: 178.27 Da
Highly lipophilic (oil:water partition coefficient = 6761:1)

• 1% solution (10 mg/mL) in white oil-in-water emulsion
• Emulsion components: soyabean oil 10%, glycerol 2.25%, egg lecithin 1.2%, water for injection, sodium hydroxide (pH adjustment)
• Appears as white, opaque, milky liquid
• pH: 6–8.5 (isotonic)
• Also available as 2% (20 mg/mL) for infusion

---

2. PHYSICOCHEMICAL PROPERTIES

Clinical pearl (Miller's 10e): Propofol supports bacterial growth at room temperature. Opened vials must be used within 6 hours; infusions completed within 12 hours. Strict aseptic technique is mandatory.

---

3. MECHANISM OF ACTION

PRIMARY MECHANISM:
Propofol → GABA-A Receptor Positive Allosteric Modulator

GABA-A receptor (pentameric ligand-gated Cl⁻ channel):
         │
         │ Propofol binds at β-subunit (transmembrane domain)
         │ (separate site from benzodiazepines)
         ▼
↑ GABA-mediated Cl⁻ channel OPENING frequency AND duration
         │
         ▼
Cl⁻ influx → HYPERPOLARISATION of neuron
         │
         ▼
↓ Neuronal excitability → CNS DEPRESSION
         │
         ▼
Sedation → Hypnosis → Anaesthesia (dose-dependent)

SECONDARY MECHANISMS:
├── NMDA receptor antagonism (minor)
├── ↓ Glutamate release (excitatory NT suppression)
├── Modulation of glycine receptors
├── Activation of 2-pore domain K⁺ channels (TREK-1)
└── Endocannabinoid system modulation

---

4. PHARMACOKINETICS

A. Absorption & Distribution

IV BOLUS → IMMEDIATE systemic absorption
              │
              ▼
Highly lipophilic → RAPID CNS penetration
Peak brain effect: 90–100 seconds
Onset of hypnosis: 30–60 seconds

THREE-COMPARTMENT MODEL:
              │
    ┌─────────┼──────────┐
    ▼         ▼          ▼
Central    Shallow    Deep
compartment peripheral peripheral
(blood/brain) compartment compartment
Vd: 6–40 L  (rapid      (slow
            equilib.)    equilib.)

Initial distribution half-life: 2–8 min
Slow distribution half-life: 30–70 min
Elimination half-life: 4–23.5 hours
Volume of distribution (steady state): 150–700 L
Clearance: 1.5–2.2 L/min (EXCEEDS hepatic blood flow)

B. Metabolism

HEPATIC (primary):
Propofol
    │
    ▼ Oxidation (CYP2B6, CYP2C9)
1,4-diisopropylquinol
    │
    ▼ Conjugation (glucuronic acid)
Propofol-1-glucuronide + Quinol-glucuronides
    │
    ▼ Renal excretion (>88% in urine)
<1% excreted unchanged

EXTRAHEPATIC (30% of total clearance):
├── KIDNEY: up to 30% of propofol clearance
│   (explains why clearance EXCEEDS hepatic blood flow)
├── LUNGS: ~20–30% first-pass uptake after bolus
└── Small intestine / other tissues

∴ Propofol does NOT accumulate significantly in
  hepatic/renal failure — extrahepatic routes compensate

C. Context-Sensitive Half-Time

Context-sensitive half-time (CSHT):
= Time for plasma concentration to fall 50%
  after stopping infusion

Propofol CSHT:
→ <40 minutes even after 8-hour infusion
→ Remains PREDICTABLY SHORT regardless of infusion duration
→ This is why propofol is IDEAL for TIVA/prolonged sedation

Compare:
│ Drug          │ CSHT at 8 hrs │
│ Propofol      │ <40 min       │ ← BEST
│ Midazolam     │ >200 min      │
│ Diazepam      │ >600 min      │
│ Thiopentone   │ >200 min      │

D. Key Pharmacokinetic Values (Miller's 10e)

---

5. DOSE

A. Standard Doses

"2 for Adults, 1 for Elderly, 3 for Children" (2 mg/kg adult | 1 mg/kg elderly | 3 mg/kg child)

---

6. PHARMACODYNAMIC EFFECTS (ORGAN SYSTEMS)

A. Central Nervous System

DOSE-DEPENDENT CNS DEPRESSION:

Sedation → Anxiolysis → Hypnosis → Anaesthesia → OD

CBF: ↓↓ (25–40% reduction)
CMRO₂: ↓↓ (proportional to CBF — coupling maintained)
ICP: ↓↓ (↓CBF → ↓CBV → ↓ICP)
CPP: ↓ (↑MAP falls but ↓ICP offsets partially)
EEG: Burst suppression at high doses
Anticonvulsant: YES (used in status epilepticus termination)
Amnesia: YES (anterograde amnesia)
Analgesia: MINIMAL (not an analgesic)
Antiemetic: YES (via D₂ receptor antagonism in CTZ)

• Propofol ↓ CBF + CMRO₂ with maintained coupling → ideal for neurosurgery
• Reduces ICP → preferred in patients with raised ICP
• Drug of choice for TIVA in neurosurgery

B. Cardiovascular System

PROPOFOL → CARDIOVASCULAR DEPRESSION

↓ Systemic Vascular Resistance (SVR)
        │
        ▼
VASODILATION (dominant effect)
        │
↓ Myocardial contractility (direct)
        │
↓ Heart rate (↓sympathetic tone + possible vagotonia)
        │
        ▼
HYPOTENSION (magnitude: ↓25–40% MAP)
Onset: slower than CNS effect (Miller's 10e)

• Elderly patients
• Hypovolaemia
• Pre-existing cardiac disease
• High dose / rapid injection
• Cardiac autonomic neuropathy (DAN)

• Slow injection (over 20–30 sec) — reduces peak plasma concentration
• Pre-loading with IV fluids
• Vasopressors (ephedrine / phenylephrine) drawn up before induction in high-risk patients
• Reduce dose in elderly/compromised patients

C. Respiratory System

PROPOFOL → DOSE-DEPENDENT RESPIRATORY DEPRESSION

↓ Tidal volume
↓ Respiratory rate → APNOEA (at induction dose)
↓ Hypoxic ventilatory response
↓ Laryngeal/pharyngeal muscle tone
→ Airway obstruction risk
Bronchodilation: MILD (useful in asthma)
Blunts laryngeal reflexes → ideal for LMA insertion

D. Other System Effects

---

7. CLINICAL USES

CLINICAL APPLICATIONS OF PROPOFOL:

A. INDUCTION OF ANAESTHESIA
   → Most common IV induction agent worldwide
   → Ideal: smooth, rapid, pleasant induction
   → Preferred for: day case surgery, ambulatory

B. MAINTENANCE — TIVA (Total IV Anaesthesia)
   → With remifentanil (gold standard TIVA)
   → With TCI (Target-Controlled Infusion)
      Marsh model: weight-based
      Schnider model: age+weight+height+LBM
   → BIS monitoring to guide depth (target 40–60)

C. SEDATION
   → Procedural sedation (endoscopy, ICU)
   → Conscious sedation for regional anaesthesia
   → ICU sedation (short-medium term)

D. NEUROSURGERY (TIVA)
   → ↓CBF, ↓CMRO₂, ↓ICP
   → Maintains coupling
   → No increase in seizure threshold monitoring

E. ANTIEMETIC
   → Subhypnotic dose (10–20 mg) — rescue antiemetic
   → Prophylaxis in high-PONV-risk patients

F. SPECIAL USES
   → Electroconvulsive Therapy (ECT) induction
   → Day-case anaesthesia (rapid emergence)
   → LMA insertion (best agent for blunting reflexes)
   → ERCP/colonoscopy sedation
   → Status epilepticus (refractory) — high-dose infusion

---

8. ADVERSE EFFECTS

A. Pain on Injection (Most Common — 28–90%)

MECHANISM:
Free aqueous-phase propofol → activates nociceptors
in vessel wall → burning/stinging pain

PREVENTION STRATEGIES (in order of evidence):
1. Use ANTECUBITAL or large forearm vein
   (avoid dorsum of hand — thin-walled, painful)
2. Lidocaine 40 mg IV (Bier's block technique):
   → Venous tourniquet → inject lidocaine 40 mg
   → Wait 30–60 sec → release tourniquet → give propofol
3. Lidocaine 1–2 mL added directly to propofol
4. Pre-treat with: ketamine 0.5 mg/kg / opioid (fentanyl) /
   metoclopramide / ondansetron
5. 2% propofol (less aqueous phase → less pain)
6. Inject slowly after blood return confirmed

B. Apnoea

• Occurs in 25–35% of induction doses
• Duration: 30–90 seconds usually
• Management: gentle mask ventilation + time

C. Propofol Infusion Syndrome (PRIS) — Critical Side Effect

PRIS DEFINITION:
Rare, potentially FATAL syndrome associated with
high-dose prolonged propofol infusion

TRIGGER DOSE (FDA):
≥4 mg/kg/hr (≥67 mcg/kg/min) for ≥48 hours
BUT cases reported at lower doses and shorter duration!

MECHANISM:
Propofol → inhibits mitochondrial respiratory chain
              (Complex I and II impaired)
              + inhibits β-oxidation of fatty acids
              │
              ▼
Mitochondrial dysfunction
              │
              ▼
Metabolic acidosis + rhabdomyolysis + lipemia

CLINICAL FEATURES:
"MARBLES" mnemonic:
M — Metabolic acidosis (base deficit > 10 mmol/L)
A — Arrhythmia (acute refractory bradycardia → asystole)
R — Rhabdomyolysis (↑CK, myoglobinaemia)
B — Bradycardia (refractory, leading to cardiac arrest)
L — Lipidaemia (hypertriglyceridaemia, lipaemic plasma)
E — Enlarged/fatty liver (hepatomegaly)
S — Skeletal myopathy

RISK FACTORS:
├── Dose >4 mg/kg/hr (>67 mcg/kg/min)
├── Duration >48 hrs
├── Children (higher risk — FDA: avoid in paediatric ICU)
├── Critical illness (high catecholamine state)
├── Low carbohydrate intake
└── Mitochondrial disease

MANAGEMENT OF PRIS:
├── STOP propofol IMMEDIATELY
├── Switch to alternative sedation
├── Supportive: correct acidosis, arrhythmia management
├── Renal replacement therapy (myoglobulinaemia)
├── Cardiac pacing if refractory bradycardia
└── Extracorporeal membrane oxygenation (ECMO) if needed

D. Other Adverse Effects

---

9. CONTRAINDICATIONS

Note on egg allergy: True egg anaphylaxis is to egg white (ovalbumin) — propofol contains egg lecithin (from egg yolk). These are different proteins. Most current guidelines (including UK Resuscitation Council) do NOT contraindicate propofol in egg allergy. However, caution is warranted in severe allergy with positive skin-prick test to egg yolk specifically.

---

10. SPECIAL SCENARIOS

Propofol in TCI (Target-Controlled Infusion)

TCI MODELS FOR PROPOFOL:

MARSH MODEL (Glaxo/Diprifusor):
→ Based on: AGE + WEIGHT only
→ Targets PLASMA concentration
→ Induction: plasma target 4–8 mcg/mL
→ Maintenance: plasma target 3–6 mcg/mL
→ Limitation: overestimates in elderly (large Vd assumed)

SCHNIDER MODEL (GE/Fresenius):
→ Based on: AGE + WEIGHT + HEIGHT + LEAN BODY MASS
→ Targets EFFECT-SITE concentration
→ Induction: effect-site target 4–6 mcg/mL
→ Maintenance: 2.5–4.5 mcg/mL
→ More accurate in elderly and extreme body habitus
→ Preferred for TIVA with remifentanil

OPTIMAL TIVA (Propofol + Remifentanil):
→ Propofol TCI effect-site 2–4 mcg/mL
→ Remifentanil TCI effect-site 2–4 ng/mL
→ BIS monitoring: target 40–60
→ Best recovery profile; minimal PONV

---

11. COMPARISON WITH THIOPENTONE

---

QUICK REVISION SUMMARY BOX

╔══════════════════════════════════════════════════════════════════╗
║               PROPOFOL — DNB DISTINCTION VIVA PEARLS            ║
╠══════════════════════════════════════════════════════════════════╣
║ Chemical: 2,6-di-isopropylphenol in soya/egg lecithin emulsion  ║
║ Mechanism: GABA-A positive allosteric modulator (β-subunit)      ║
║ Onset: 30–60 sec | Peak brain effect: 90–100 sec                ║
╠══════════════════════════════════════════════════════════════════╣
║ DOSES:                                                           ║
║ Induction: 1.5–2.5 mg/kg (adult); 1 mg/kg (elderly);           ║
║            2.5–3.5 mg/kg (child)                                 ║
║ TIVA maintenance: 100–200 mcg/kg/min                            ║
║ Sedation: 25–75 mcg/kg/min                                      ║
║ Antiemetic: 10–20 mg IV (subhypnotic)                           ║
║ PRIS threshold: >4 mg/kg/hr for >48 hrs                         ║
╠══════════════════════════════════════════════════════════════════╣
║ PHARMACOKINETICS:                                                ║
║ Clearance: 1.5–2.2 L/min (EXCEEDS hepatic blood flow)          ║
║ Extrahepatic: kidney (30%) + lung (20–30%)                      ║
║ CSHT: <40 min at 8 hrs (ideal for TIVA)                         ║
║ Elderly need 50% of adult dose (↓Vd, ↓CO, ↑sensitivity)        ║
╠══════════════════════════════════════════════════════════════════╣
║ PRIS = "MARBLES":                                                ║
║ Metabolic acidosis | Arrhythmia | Rhabdomyolysis |              ║
║ Bradycardia | Lipidaemia | Enlarged liver | Skeletal myopathy   ║
╠══════════════════════════════════════════════════════════════════╣
║ TCI MODELS: Marsh (plasma, age+weight) |                        ║
║             Schnider (effect-site, age+wt+ht+LBM)              ║
╠══════════════════════════════════════════════════════════════════╣
║ PAIN ON INJECTION: Use antecubital vein + lidocaine 40 mg       ║
║ GREEN URINE: benign propofol metabolites (quinol glucuronide)   ║
╠══════════════════════════════════════════════════════════════════╣
║ UNIQUE ADVANTAGES:                                               ║
║ ✓ Antiemetic | ✓ Anti-pruritic | ✓ ↓ICP | ✓ Bronchodilator    ║
║ ✓ Short CSHT (TIVA) | ✓ LMA insertion | ✓ Day-case ideal        ║
╠══════════════════════════════════════════════════════════════════╣
║ COMMON EXAM MISTAKES:                                            ║
║ ✗ Propofol is an analgesic — IT IS NOT                          ║
║ ✗ PRIS occurs only with long infusions — low dose cases exist   ║
║ ✗ Egg allergy is absolute contraindication — evidence weak      ║
║ ✗ Context-sensitive half-time increases with duration — NO      ║
║   (Propofol CSHT stays <40 min up to 8 hr infusion)            ║
╚══════════════════════════════════════════════════════════════════╝

---

Self-Review of Previous Propofol Answer

---

ERRORS, UNSUPPORTED CLAIMS & ISSUES FOUND

---

SUMMARY OF ISSUES

---

---

PROPOFOL

DNB Final Anaesthesia | 10-Mark Distinction-Level Answer (Revised)

---

1. INTRODUCTION

---

2. PHYSICOCHEMICAL PROPERTIES

Chemical name: 2,6-di-isopropylphenol
Molecular weight: 178 Da
Appearance: White, opaque oil-in-water emulsion
pH: 6–8.5
Protein binding: 97–99%
Highly lipophilic → rapid CNS penetration

Clinical point: The emulsion supports bacterial growth at room temperature. Opened vials must be used within 6 hours; infusions completed within 12 hours. Strict aseptic technique is mandatory. (Miller's 10e)

---

3. MECHANISM OF ACTION

Primary — GABA-A Receptor Potentiation

PROPOFOL
    │
    ▼ Binds transmembrane domain of β-subunit
    │ of GABA-A receptor
    ▼
↑ Duration and frequency of Cl⁻ channel OPENING
in response to GABA
    │
    ▼
↑ Cl⁻ influx → neuronal HYPERPOLARISATION
    │
    ▼
↓ Neuronal excitability → CNS depression
    │
    ▼
Sedation → Hypnosis → Anaesthesia (dose-dependent)

• Benzodiazepines bind the α-γ interface (increase frequency of channel opening)
• Propofol binds the β-subunit transmembrane domain (increases both frequency AND duration)
• At high concentrations, propofol can directly activate GABA-A receptor without GABA

Secondary Mechanisms (established evidence)

• NMDA receptor antagonism — contributes to anaesthetic effect at higher concentrations
• Sodium channel inhibition — contributes to analgesic-sparing effects
• Glycine receptor modulation — inhibitory neurotransmission enhancement

---

4. PHARMACOKINETICS

Three-Compartment Model

IV BOLUS
    │
    ▼
CENTRAL COMPARTMENT (blood, vessel-rich organs)
Vd central: 6–40 L
    │
    ├──────────────────────┐
    ▼                      ▼
SHALLOW PERIPHERAL     DEEP PERIPHERAL
COMPARTMENT            COMPARTMENT
(rapid equilibration)  (slow equilibration)
Vd steady state: 150–700 L

DISTRIBUTION half-lives:
  Initial: 2–8 minutes
  Slow: 30–70 minutes
ELIMINATION half-life: 4–23.5 hours
CLEARANCE: 1.5–2.2 L/min

Metabolism

HEPATIC (~70% of total):
Propofol → Oxidation → 1,4-diisopropylquinol
         → Conjugation (glucuronic acid)
         → Propofol glucuronide + Quinol glucuronides
         → Renal excretion (>88% in urine)
<1% excreted unchanged in urine

EXTRAHEPATIC (~30%):
├── KIDNEY: up to 30% of clearance
│   (confirmed during anhepatic phase of liver transplant)
└── LUNG: ~20–30% first-pass uptake after bolus dose

∴ Clearance (1.5–2.2 L/min) EXCEEDS hepatic blood flow
→ Extrahepatic sites account for this
→ Relatively preserved in liver disease

Context-Sensitive Half-Time (CSHT)

CSHT = time for 50% fall in plasma concentration
       after stopping infusion

PROPOFOL:
Infusion duration    CSHT
0–8 hours      →    <40 minutes (CONSISTENTLY SHORT)

COMPARE:
Midazolam 3 hrs → ~200 min
Thiopentone 3 hrs → >200 min
Propofol 8 hrs → <40 min ← UNIQUE ADVANTAGE

∴ Propofol is IDEAL for prolonged infusions/TIVA
  Recovery remains PREDICTABLE regardless of duration

Key Pharmacokinetic Values

Age and Special Population Effects

ELDERLY (>65 years):
├── ↓ Cardiac output → smaller central compartment
├── ↓ Clearance
├── ↑ CNS sensitivity (same drug level → deeper effect)
└── RESULT: Need ~50% of adult dose
    (Miller's 10e: "patients aged 80 generally need
    50% of propofol dose of 20-year-old patients")

CHILDREN (<8 years):
├── Larger Vd per kg → larger dose needed
├── Faster clearance
└── ED95 for induction HIGHER than adults
    (2.88 mg/kg in <2 years — Miller's 10e)

WOMEN:
├── Larger Vd + higher clearance than men
└── Elimination t½ similar to males

---

5. DOSES

"2 – 1 – 3" Adult = 2 mg/kg | Elderly = 1 mg/kg | Child = 3 mg/kg

---

6. PHARMACODYNAMIC EFFECTS

A. Central Nervous System

B. Cardiovascular System

PROPOFOL → CARDIOVASCULAR DEPRESSION

PRIMARY: ↓ Systemic Vascular Resistance (vasodilation)
SECONDARY: ↓ Myocardial contractility (direct, dose-dependent)
TERTIARY: ↓ Heart rate (↓sympathetic tone)
          (occasionally vagotonia → bradycardia)

RESULT:
↓ MAP: 25–40% fall at induction
Onset of BP fall: SLOWER than CNS effect
                  (doubles the time — Miller's 10e)
Elderly: onset of ↓BP increases further with age

RISK FACTORS FOR SEVERE HYPOTENSION:
├── Elderly / low body weight
├── Hypovolaemia
├── Pre-existing cardiac disease / low ejection fraction
├── Rapid injection rate
└── High induction dose

C. Respiratory System

DOSE-DEPENDENT RESPIRATORY DEPRESSION:
├── ↓ Tidal volume + ↓ RR → APNOEA (at induction)
│   (25–35% incidence at standard doses)
├── ↓ Hypoxic ventilatory response
├── ↓ Laryngeal / pharyngeal muscle tone
│   → Airway obstruction
├── Blunts laryngeal reflexes (better than thiopentone)
│   → IDEAL for LMA insertion
└── MILD bronchodilation (useful in reactive airway disease)

D. Other Effects

---

7. CLINICAL USES

1. INDUCTION OF ANAESTHESIA
   → Most widely used IV induction agent
   → Smooth, rapid, pleasant

2. TIVA MAINTENANCE
   → With remifentanil (gold standard TIVA combination)
   → Guided by TCI (Marsh or Schnider models)
   → BIS monitoring target: 40–60

3. SEDATION
   → Procedural (endoscopy, radiology, ICU)
   → Supplement to regional anaesthesia
   → Short-term ICU sedation

4. NEUROSURGERY
   → ↓ICP, ↓CBF, ↓CMRO₂ with maintained coupling
   → Preferred for TIVA in intracranial procedures

5. ANTIEMETIC
   → Subhypnotic dose (10–20 mg IV)
   → High-PONV-risk patients

6. SPECIAL USES
   → LMA insertion (superior laryngeal reflex blunting)
   → Day-case / ambulatory surgery
   → ECT induction (short, smooth, rapid recovery)
   → Refractory status epilepticus (high-dose infusion)

---

8. ADVERSE EFFECTS

A. Pain on Injection (most common, 28–90%)

MECHANISM:
Free propofol in aqueous phase activates kinin
cascade and direct nociceptor activation
→ Burning/stinging on injection

PREVENTION (evidence-based):
1. Use large vein (antecubital fossa preferred)
   Avoid dorsum of hand
2. Lidocaine pre-treatment:
   a) Bier's block: tourniquet → lidocaine 40 mg IV
      → wait 30–60 sec → release → inject propofol
   b) Lidocaine 1–2 mL mixed with propofol
3. Pre-treat with fentanyl/opioid 1–2 min before
4. Slow injection rate
5. 2% formulation (lower aqueous phase)

B. Haemodynamic Depression

• ↓MAP 25–40% — manage with fluid preload + vasopressors
• Ephedrine 6–12 mg or phenylephrine 50–100 mcg drawn up before induction in high-risk patients

C. Apnoea

• 25–35% incidence at standard induction doses
• Manage with gentle bag-mask ventilation

D. Propofol Infusion Syndrome (PRIS)

DEFINITION: Rare, potentially fatal syndrome
associated with high-dose prolonged propofol infusion

TRIGGER (FDA / Miller's 10e):
≥4 mg/kg/hr (≥67 mcg/kg/min) for ≥48 hours
BUT cases reported at lower doses and shorter duration

PATHOPHYSIOLOGY:
Propofol → inhibits mitochondrial electron
transport chain (Complex I and II)
+ impairs β-oxidation of fatty acids
         │
         ▼
Cellular energy failure → organ dysfunction

CLINICAL FEATURES (Miller's 10e):
• Acute refractory bradycardia → asystole (cardinal feature)
• Metabolic acidosis (base deficit >10 mmol/L)
• Rhabdomyolysis (↑CK, myoglobinaemia)
• Hyperlipidaemia (lipaemic plasma)
• Enlarged or fatty liver (hepatomegaly)
• Skeletal myopathy
• Cardiomyopathy with acute cardiac failure
• Hyperkalemia

RISK FACTORS:
├── Dose >4 mg/kg/hr, duration >48 hrs
├── Children (FDA: contraindicated for prolonged
│   paediatric ICU sedation)
├── Critically ill patients
├── Low carbohydrate intake
└── Concomitant catecholamine/steroid infusions

MANAGEMENT:
├── STOP propofol IMMEDIATELY
├── Switch to alternative sedative
├── Treat arrhythmia / metabolic acidosis
├── Renal replacement therapy if needed
└── ECMO in refractory cardiogenic shock

E. Other Adverse Effects

---

9. CONTRAINDICATIONS

Egg/soy allergy note: Propofol contains egg-derived phosphatide (lecithin from yolk) and soyabean oil. The evidence that egg allergy (typically to egg white ovalbumin) constitutes a contraindication is not strong, but caution and allergy history review are prudent. Seek allergy specialist advice in severe documented allergy before use.

---

10. TCI (Target Controlled Infusion) — Propofol Models

---

QUICK REVISION SUMMARY BOX

╔══════════════════════════════════════════════════════════════════╗
║               PROPOFOL — DNB DISTINCTION VIVA PEARLS            ║
╠══════════════════════════════════════════════════════════════════╣
║ INTRODUCED: 1977 (synthesised); 1986 (lipid emulsion launched)  ║
║ CLASS: 2,6-di-isopropylphenol | MECHANISM: GABA-A β-subunit     ║
║ APPEARANCE: White milky emulsion (NOT colourless)                ║
╠══════════════════════════════════════════════════════════════════╣
║ DOSES — "2–1–3 Rule":                                            ║
║ Adult 2 mg/kg | Elderly 1 mg/kg | Child 3 mg/kg                 ║
║ TIVA: 100–200 mcg/kg/min | Sedation: 25–75 mcg/kg/min          ║
║ Antiemetic: 10–20 mg IV | Max infusion: <5 mg/kg/hr             ║
╠══════════════════════════════════════════════════════════════════╣
║ PK HALLMARKS:                                                    ║
║ Clearance 1.5–2.2 L/min EXCEEDS hepatic blood flow              ║
║ Extrahepatic: kidney (30%) + lung (20–30%)                      ║
║ CSHT <40 min at 8 hrs — UNIQUE — ideal for TIVA                 ║
║ Elderly need 50% of adult dose (Miller's 10e)                   ║
╠══════════════════════════════════════════════════════════════════╣
║ CNS: ↓CBF + ↓CMRO₂ (coupling maintained) + ↓ICP               ║
║ CVS: ↓MAP 25–40% (vasodilation dominant)                        ║
║ RESP: Apnoea 25–35%; blunts laryngeal reflexes → LMA ideal      ║
╠══════════════════════════════════════════════════════════════════╣
║ PRIS — KEY FEATURES (Miller's 10e):                             ║
║ Trigger: >4 mg/kg/hr × >48 hrs (lower doses reported too)       ║
║ Features: Refractory bradycardia/asystole + metabolic           ║
║           acidosis + rhabdomyolysis + ↑lipids + fatty liver     ║
║ Management: STOP infusion immediately                           ║
╠══════════════════════════════════════════════════════════════════╣
║ UNIQUE ADVANTAGES vs ALL OTHER IV AGENTS:                       ║
║ ✓ Antiemetic ✓ Anti-pruritic ✓ Short CSHT ✓ ↓ICP              ║
║ ✓ Bronchodilator ✓ Anticonvulsant ✓ LMA insertion              ║
║ ✓ Day-case ideal ✓ TIVA backbone                                ║
╠══════════════════════════════════════════════════════════════════╣
║ COMMON EXAM MISTAKES:                                            ║
║ ✗ Propofol is analgesic — NO: minimal analgesia                 ║
║ ✗ PRIS only with long high-dose infusions — cases at low dose   ║
║ ✗ CSHT increases progressively with duration — NO for propofol  ║
║ ✗ Propofol 1986 not 1977 (1977 = synthesis, 1986 = emulsion)   ║
╚══════════════════════════════════════════════════════════════════╝

---

CONFIDENCE RATING: 9/10

• Core pharmacology, doses, mechanism, PK values — all cross-referenced directly against Miller's Anaesthesia 10e retrieved text → high confidence
• PRIS features and thresholds — directly cited from Miller's retrieved text → high confidence
• TREK-1/endocannabinoid mechanisms from previous answer — removed (not textbook-verified)
• Specific CYP isoforms — removed (not in retrieved text)
• "MARBLES" mnemonic — replaced with direct listing of features per Miller's text
• TCI model details (Marsh/Schnider) — based on established pharmacology literature, not retrieved text → flagged as knowledge-based, not textbook-cited (-0.5 confidence)
• Pain-on-injection mechanisms and prevention strategies — well-established, consistent with textbook content (-0.5 confidence for one point)